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CHAPTER 1 
1.1 Introduction to the Problem 
The concept of having neural electrodes located within the brain to stimulate and record 
signals in order to treat neurological disorders is very exciting, however, to this day, the ability to 
design a stable, long-term device has failed (Polikov et al., 2006).  For approximately three 
decades, researchers have been attempting to develop neuroprosthetic devices that can re-
establish lost functions after nervous system injury (Szarowski et al., 2003).  Two of the most 
successful neural advances made thus far are the deep brain stimulators used to treat 
neurodegenerating diseases such as Parkinson’s disease and the use of cochlear implants to 
improve hearing in the deaf (Szarowski et al., 2003).  It is the formation of electrical connections 
with neural dendrites and axons, that controls the functionality of a microelectrode 
neuroprosthetic device (Turner et al., 1999). At the minimum, there needs to be electrical 
connections to the surrounding tissue to record field and single-unit potentials (Turner et al., 
1999).   
The damage to the brain tissue caused by neural electrode insertion reduces the lifespan 
of the electrode (Frampton et al., 2010; Szarowski et al., 2003; Yuen et al., 1981).  Implantation 
of such devices has been shown to lead to changes in gene expression, increased cell 
proliferation, compromised blood-brain barrier integrity, infiltration of circulating macrophages, 
intermittent ischemia, and generation of reactive oxygen species and inflammatory cytokines 
(Frampton et al., 2010; Griffith and Humphrey, 2006; McCreery and Agnew, 1983; Szarowski et 
al., 2003; Turner et al., 1999).  Moreover, the sustained presence of the neural electrode results in 
increased glial cell volume and migration to and proliferation of activated glial cells at the 
2 
 
 
device-tissue interface (Frampton et al., 2010; Polikov et al., 2006; Szarowski et al., 2003; 
Turner et al., 1999).  This response culminates in the formation of a fibrous and cellular sheath, 
covered by activated glial cells, encapsulating the neural electrode.  Consequently preventing the 
recording and stimulation of neurons, which results in the inconsistent and unreliable device 
performance (Frampton et al., 2010; Polikov et al., 2005; Yuen et al., 1981) .   
Some approaches towards reducing the tissue encapsulating sheath created by gliosis 
include targeting the problem at the site of insertion.  It has been thought, that if the initial 
insertion tissue damage is minimized then the encapsulating sheath may accordingly be reduced 
(Szarowski et al., 2003; Yuen et al., 1981).  It has been shown that device size and insertion 
speed play important roles in reducing the amount of insertion-related damage (Szarowski et al., 
2003; Yuen et al., 1981).  However, little is known on the role of other physical factors including 
device geometry and texture on reducing this tissue damage.  Literature has shown that surface 
topography modifications can alter cell alignment, adhesion, proliferation, migration, and gene 
expression (Agnew et al., 1983; Cogan et al., 2005; Cogan et al., 2006; Merrill et al., 2005).  
Thus, the goal of this proposed work is to study surface topography effects on minimizing 
astrogliosis.   
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1.2 Hypothesis and Specific Aims 
Neural electrodes show promise for the treatment of neurodegenerative disease, however, 
failure of the electrode has been inevitable following chronic implantation of the current devices.  
Glial scar formation around the electrode consequently forms a barrier preventing neuronal 
processes from reaching the electrode.  Current research to alleviate the inflammatory and 
chronic immune response on electrodes focuses on altering the electrode size, materials, protein 
and drug coatings, and surface topographies.  Research has shown that alterations in surface 
topography, such as nanopatterning, have significant effects to cellular and molecular behavior 
of cells.  Nanopatterning has been reported to alter cellular adhesion, migration, proliferation, 
viability, morphology, alignment, differentiation, and gene expression.  The majority of reports 
focus on neuronal response to materials, however, the glial response may likely predict this 
neuronal behavior.  There is a gap in the knowledge base of how glial cells respond to 
nanopatterned surfaces.  This information could lead to improved electrode designs which reduce 
the inflammatory effect and prevent glial scar formation.   
Specific Aims: 
1.  Characterization of astrocyte reactivity and gene expression on biomaterials for neural 
electrode fabrication.   
• Investigate the reactivity of C6 glioma cell line on four biomaterials used in neural 
electrode fabrication 
• Materials to be tested include platinum, silicon, PMMA, and SU8.  Polystyrene will serve 
as the control material.   
• Astrocyte reactivity will be determined in terms of proliferation, gene expression of 
reactivity and proliferation factors, and cellular morphology.   
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• Identification of material to serve as the substrate to be nanopatterned (for aims 2-3).   
Hypothesis: Each biomaterial will elicit a different response from the astrocytes.  Astrocyte 
reactivity to these materials will vary according to proliferation, GFAP expression, viability and 
morphology.  A compatible material will have cells with low levels of GFAP expression, steady 
proliferation rate, minimum 80% viability, and spread out cells with round nuclei.    
 
2.  Evaluation of protein and cellular response to nanopatterning. 
• Determine if nanopatterning of a material will alter C6 astrocyte proliferation, viability, 
gene expression, morphology and alignment.   
• Examine the effects nanopatterning has on ECM protein adhesive rate, quantity of 
adsorption, and alignment with the nanopattern.     
Hypothesis: The nanopatterned surface will reduce the reactivity of the astrocytes as compared 
to the non-patterned surface.   Moreover, the nanopattern surface will reduce the adsorption of 
the ECM proteins.    
 
3.  Comparative assessment of iridium oxide and platinum alloy wires using an in vitro glial scar 
assay 
• Culture iridium oxide and platinum alloy wires with a mixed primary brain cells 
(consisting of astrocytes, microglia and neurons) 
• Examine the glial scar thickness around the wires after seven days in vitro. 
• Quantify through immunostaining the amount of cells around the wires. 
• Determine the astrocyte reactivity through GFAP relative gene expression.   
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Hypothesis: The glial scar assay will be effective in assessing the biocompatibility of the 
materials.  A glial scar will grow around both materials due to the foreign body inflammatory 
reaction.   
 
4.  Assessment of organotypic brain slice response on nanopatterned polydimethylsiloxane 
surface 
• Culture organotypic brain slices with a nanopatterned and non-patterned substrate.   
• Observe the gene expression of activity and cytokine factors.   
• Determine through immunostaining and SEM the alignment of astrocytes on the 
nanopatterned surface. 
Hypothesis: The nanopatterning will inhibit the inflammatory cascade and astrocytes will align 
along the nanopattern.   
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CHAPTER 2 
2.1 Overview of the Central Nervous System Cells    
The brain is a complex organ principally composed of neurons and glial cells.  Astrocytes 
make up 30-65% of glial cells in the brain.  Astrocytes are multifunctional cells whose roles 
range from homeostatic, information processing, and response to CNS injury (Buffo et al., 2010).  
Microglia compose 5-12% of total glial cells in the brain (Parekkadan et al., 2008). Microglia 
functions as the macrophage of the CNS, arriving first at the site of injury initiating the 
inflammatory cascade (Parekkadan et al., 2008).  Neurons make up less than 25% of the cells in 
the brain; they are responsible for information processing and control of bodily functions 
(Polikov et al., 2005).  These cells all work together to maintain a physiological homeostasis and 
functionality.     
2.1.1 Astrocytes 
Astrocytes cellular extensions give them a star-like appearance in vitro culture.  
Astrocyte functions include providing growth cues to neurons during Central Nervous System 
(CNS) development, mechanically support the mature neuronal circuits, buffer neurotransmitters 
and ions released during neuronal signaling, help control the chemical environment of the 
neurons, transfer of nutrients across the blood brain barrier, and modulate the firing activity of 
neurons (Fitch and Silver, 2008; Negi et al., 2010a; Polikov et al., 2005).  Astrocytes are a major 
source of extracellular matrix proteins (ECM) and adhesion molecules such as laminin, 
fibronectin, cytotactin, J-1 family members janusin and tenascin, and nerve cell adhesion 
molecule (N-CAM) (2003; Miller and Peppas, 1985).  They produce growth factors to regulate 
the morphology, proliferation, differentiation, and survival of neuronal subpopulations in vivo 
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and in vitro.  Astrocytes contain ion channels for K+, Na+, Cl-, HCO3, and Ca2+ (2003; Dow and 
Wang, 1998; Nimmerjahn, 2009).     
Astrocytes have processes that form a 15um thick barrier between the pia matter and the 
cerebral cortex neurons, called the glia limitans.  This barrier separates and protects the CNS 
from non-CNS structures.  Furthermore, astrocytes are responsible for blocking off damaged 
areas after injury from the healthy brain tissue (Fitch and Silver, 2008; Nimmerjahn, 2009).  
Astrocytes are characterized by their intermediate filaments made up of polymerized glial 
fibrillary acidic protein (GFAP).  These filaments are 45-60 kDa, 8-10nm in diameter, many 
micrometers long, and are considered to be astrocyte specific cell markers (2003; Negi et al., 
2010a; Polikov et al., 2005).   
Astrocytes become activated in reaction to injury (Buffo et al., 2010).  Activated 
astrocytes are hypertrophic, hyperplastic, have an upregulation of intermediate filaments GFAP 
and vimentin expression, and filament formation (Buffo et al., 2010; Gervasi et al., 2008).  
Studies have shown vimentin expression in mature reactive astrocytes, microglia and 
perivascular cells (Polikov et al., 2006; Szarowski et al., 2003).  Activated astrocytes have a 
change in number and distribution of cellular organelles and glycogen deposits and an increase in 
matrix production and migration (Polikov et al., 2005; Seker et al., 2010).  Reactive astrocytes 
are formed locally and spread to farther sites (2003; Seker et al., 2010; Turner et al., 1999).  
Studies have shown a variety of cytokines involved with either the initiation or modulation of 
reactive astrogliosis (Farina et al., 2007; John et al., 2003; Liberto et al., 2004; Rao et al., 2012).  
These cytokines include interleukin-1beta (IL-1β), tumor necrosis factor alpha (TNFα), and 
transforming growth factor beta 1 (TGFβ1), of which astrocytes express receptors and result in 
an astrocytic reactive response (Farina et al., 2007; John et al., 2003; Liberto et al., 2004; Rao et 
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al., 2012).  Astrocyte-derived cytokines such as IL-1β and TNFα are considered to promote 
neurotoxicity whereas TGFβ1 acts as a neuroprotective (Farina et al., 2007; John et al., 2003; 
Liberto et al., 2004; Rao et al., 2012). 
 
 
Figure 1. Schematic representation of a normal versus reactive astrocyte and their properties (Polikov et 
al., 2005). 
2.1.2 Microglia 
Microglia are termed the macrophages of the CNS and function as the “resident 
representatives of the immune system in the brain” (2003).  Microglia enter the brain by blood-
born hematopoetic cells through a prenatal infiltration.  Microglia continuously migrate and 
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sample their local environment, unsurprisingly they are the first cell at the site of injury.  They 
rapidly respond to protect neurons by releasing trophic and anti-inflammatory factors 
(Parekkadan et al., 2008).  Microglia react to injury either by acting as phagoctyes or cytotoxic 
cells; they degrade extracellular matrix and cellular debris by secreting proteolytic enzymes and 
kill pathogenic organisms (Fitch and Silver, 2008; Polikov et al., 2005).  Microglia are an 
immediate source for pro-inflammatory cytokines such as IL-1α, IL-1β, IL-6, and TNF-alpha, 
and the chemokine MCP-1 used in the recruitment of macrophages and microglia activation 
(Fujii et al., 2010; Parekkadan et al., 2008).  They are known to release neurotrophic factors such 
as NGF, BDNF, and NT-3 which aid in neuronal growth and survival (Parekkadan et al., 2008).  
Microglia display an increased expression of leukocyte-associated molecules, such as CD68 and 
Mac-1/CD11b, recognized by the ED-1 and OX-42 antibody respectively (Polikov et al., 2005; 
Szarowski et al., 2003).  Following injury, microglia are known to secrete various cytotoxic and 
neurotoxic factors that can lead to neuronal death.  These include excitory amino acids, such as 
glutamate, reactive oxygen intermediates, such as hydrogen peroxide, and reactive nitrogen 
intermediates, such as nitric oxide.   Studies have shown that the inability of a foreign body to be 
removed will result in the constant release of these neurotoxic factors (Polikov et al., 2005).    
Activated microglia have an increased proliferation, more compact “amoeboid” 
morphology, phagocytose foreign material, and upregulate lytic enzyme production for foreign 
body degradation (Figure 2) (Polikov et al., 2005).  Microglia play a dominant role in the acute 
inflammatory response to a foreign body (Fujii et al., 2010; Parekkadan et al., 2008; Polikov et 
al., 2005).  Microglia cluster around the foreign body within the reactive glial scar until the 
implanted device is removed (Polikov et al., 2006).     
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Figure 2. Schematic representation of a normal versus activated microglia and their properties (Polikov et 
al., 2005). 
2.1.3 Neuron 
Neurons they are responsible for information processing and control of bodily functions 
(Polikov et al., 2005).  Neurons have three major regions: the cell body (perikaryon) containing 
the nucleus and major organelles, numerous dendrites and a single axon (Figure 3).  Dendrites 
originate from the cell body, differ in shape and size and branch into the grey matter while axons 
can extend much further form the cell body and make up the white matter (2003).                                                
Some axons are covered in an insulating myelin sheath which facilitates rapid impulse 
conduction which originates at the axon hillock as an action potential (2003).  The CNS is made 
up of different types of neurons, including excitatory pyramidal neurons found in the cerebral 
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cortex and interneurons (2003).  Pyramidal neurons are highly polarized, with a triangular 
shaped body, numerous dendrites that can spread over several millimeters and an axon that spans 
from the base of the cell body towards the subcortical white matter (2003).  Neurotransmitters in 
pyramidal neurons are glutamate and aspartate.  Interneurons can be excitatory or inhibitory.  
Spiny stellate cells are excitatory interneurons, they resemble pyramidal neurons in that they 
have large numbers of dendritic spines and use either glutamate or aspartate as their 
neurotransmitter (2003).   There are a large variety of inhibitory interneurons found in the 
cerebral cortex, varying in size and shape, although they all use γ-aminobutyric acid (GABA) as 
their neurotransmitter (2003).  Interneurons are found in the gray matter of the cerebral cortex, 
for their dendrites and axons do not spread very far (2003).               
 
Figure 3. Illustration of a neuron (Cogan et al., 2010). 
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2.2 Injury/Glial Scar 
The insertion of a micro-electrode device through cortical tissue severs capillaries, ECM, 
glial and neuronal cell processes.  As the electrode is inserted deeper into the tissue, the damage 
to the ECM produces a high-pressure region surrounding the electrode (Polikov et al., 2005).  
The disruption of blood vessels initiates the release of erythrocytes, activates platelets, clotting 
factors, and the complement cascade for the recruitment of macrophages and initiates tissue 
rebuilding (Polikov et al., 2005).  The inflammatory response within the brain tissue is 
characterized by the presence of reactive astrocytes and microglia.  As early as one day post 
injury, activated microglia surround the implant (Kidambi et al., 2010; Szarowski et al., 2003).  
Studies have shown microglia and astrocytes remain at the surface of implanted biomaterials for 
up to nine months after implantation (Griffith and Humphrey, 2006; Morin et al., 2006; Morin et 
al., 2005; Morino et al., 2010; Polikov et al., 2005; Szarowski et al., 2003; Turner et al., 1999).  
Therefore, it is thought that these cells remain at the surface as long as the material remains in 
contact with brain tissue (Polikov et al., 2005).  Moreover, it has been shown that cells forming 
the glial sheath appear to have migrated from nearby tissue (Turner et al., 1999).   
The long-term effect of chronically implanted electrodes is the formation of a glial scar 
made up of reactive astrocytes and the matrix proteins they generate (Polikov et al., 2005; Rose 
et al., 1985).  Astrocytes are reported to become activated from as far as 500 μm away from an 
electrode insertion site (Polikov et al., 2006; Polikov et al., 2005).  Over time, the glial scar 
decreases in thickness, becoming denser and more organized (Polikov et al., 2006; Szarowski et 
al., 2003).  Studies have shown glial scars from retrieved devices two weeks post implantation 
were 500-600 μm thick (Polikov et al., 2006; Szarowski et al., 2003; Turner et al., 1999).  
Several reasons have been hypothesized for glial scar formation such asunresolved acute 
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inflammation, toxicity of the device material, chronic movement between the device and brain 
tissue (Polikov et al., 2006; Szarowski et al., 2003; Turner et al., 1999).  The glial scar functions 
to encapsulate the electrode, separating the damaged brain tissue and the foreign device from the 
undamaged, healthy tissue (Polikov et al., 2005).  This encapsulation leads to an increasing 
distance between the electrode and its target neurite processes.  Thus, increasing the impedance 
of the electrode and decreasing signal strength (Polikov et al., 2005).  The strength and quality of 
the recorded electrical signal is determined by the location of the neuron in relation to the 
electrode recording sites.  In order to maintain a recording and accurately observe action 
potentials, the maximum distance between neuron and electrode, commonly referred to as the 
“kill zone”,  can only be between 50-100 μm (McCreery and Agnew, 1983; Polikov et al., 2005; 
Turner et al., 1999; Wang et al., 2011).    Studies have shown that the molecular composition of 
the glial scar and the production of inhibitory molecules by reactive astrocytes impair axon 
regeneration (2003; Rose et al., 1985).  The astrocytes in the glial scar upregulate inhibitory 
molecules, such as, chondroitin sulfate proteoglycans (CSPGs), tenascin, Semaphorin 3, ephrin-
B2, and slit proteins which play a role in the CNS axons inability to regenerate (Fitch and Silver, 
2008).  It has been shown that reactive astrocytes secrete proteoglycans that inhibit the growth of 
neuritis in injured spinal cord and brain models (Griffith and Humphrey, 2006). 
2.2.1 Time Course of Glial Scar in vivo 
Turner et al quantitatively studied astrocyte activation, morphology, and distribution 
changes to silicone probes in vivo (Polikov et al., 2005; Turner et al., 1999).  They determined 
the time course for glial scar formation through the use of Confocal and scanning electron 
microscopy.  Two weeks after a silicon electrode was implanted into a rat cerebral cortex, 
reactive astrocytes surrounded the implant site as far as 500-600um away.  By four weeks, the 
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reactive astrocytes adjacent to the implant became denser and spread their processes around the 
insertion site.  The web of astrocytes was observed to become denser by the six and 12 week 
time intervals (Polikov et al., 2005; Turner et al., 1999). Observations revealed a collapse of the 
insertion sites when the  probe was removed after two and four weeks, but remained intact when 
the probe was removed at weeks six and 12 (Figure 4).  (Turner et al., 1999).  Furthermore, the 
formation of the glial scar was found to be much faster than the regrowth of neuronal axons, 
resulting in a high resistance barrier preventing the axons from extending.  They concluded that 
studies earlier than two weeks are required to fully understand the formation of the glial scar.   
 
Figure 4.  SEM images of (A) a 2 week probe and (B) a 6 week probe covered in layers of cells.  The 
insert in (A) are magnified view of red blood cells attached to the probe.  Confocal microscopy images of 
GFAP stained insertion sites at (C) 2 weeks and (D) 6 weeks (Turner et al., 1999).   
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Several years later, the same group studied time effects when varying the geometries of 
the probes and observing the tissue response starting at one day post implantation (Szarowski et 
al., 2003).  GFAP staining revealed astrocytes were activated 100-200 μm away from the implant 
site one day post implantation.  By the second week, GFAP-positive cells aligned around the 
device site.  At week four, the encapsulation was 50-100 μm thick (Szarowski et al., 2003).  
Similarly to their previous study, astrocyte activation continued to spread up to 500 μm away 
from the implant site by the fourth week (Polikov et al., 2005; Szarowski et al., 2003; Turner et 
al., 1999).  At six weeks the sheath thinned down to a compact 25-50 μm thick layer around the 
insertion site and remained constant up to week 12 (Szarowski et al., 2003).   Szarowski et al 
also stained for vimentin expression.  They found similar results to GFAP staining, however with 
much fewer cells making a 25-50 μm sheath thickness completed by week four.   ED1 was 
utilized to stain for reactive microglia.  Observations showed ED1-positive cells after one day 
around the insertion sites.  By one week, the ED1-positive microglia covered an area three to 
four times as large as the initial insertion site.  The microglia closest to the insertion site had 
short, thick processes, while the ones further away were elongated.  By two weeks, the lumen of 
the site was filled with stained materials.  The ED-1-positive microglia formed a 100-200um 
thick layer by the fourth week.  Similar to the GFAP and vimentin positive staining, the sheath 
was more compact by the sixth week, which continued to thin out by week 12.   
Szarowski et al demonstrated that the reactive cellular response, although expected 
during the first two weeks, are still found up to 12 weeks after device insertion (Figure 5).  This 
suggests that the astrocytes and microglia are continuously being activated (Szarowski et al., 
2003).  It is believed that the cascade of events, beginning with the rupture of vessels when the 
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device is inserted, is related to the long term activation of the astrocytes and microglia 
(Szarowski et al., 2003).   Furthermore, they concluded that the device size plays an important 
role in reducing the amount of insertion-related damage (Polikov et al., 2005; Szarowski et al., 
2003).   
 
Figure 5.  Devices removed from brains at 1 day and 1, 6, 12 weeks post insertion.  GFAP (red) and 
nuclear stain (green), nuclei associated with GFAP-positive cells (yellow) (Szarowski et al., 2003).     
 
2.2.2 In vitro glial scar models 
After two decades of in vivo testing, the mechanism depicting the failure of chronic 
neural electrodes is still unclear.  In vitro studies allow for the control at a molecular level in 
which the mechanisms of failure can be understood.  However, there have been a limited number 
of studies creating an in vitro glial scar environment.  Polikov et al proposed an in vitro model of 
glial scarring by culturing primary mixed brain cells, made up of neurons, astrocytes, and 
microglia.  They injured the cell monolayer through a mechanical scrape followed by placement 
of a stainless steel wire near the scrape (Polikov et al., 2006).  They found that astrocytes began 
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to extend their processes six hours post scrape injury and completely covered the site by day 
seven.  Astrocytes around the scrape had fewer and thicker processes.  Microglia entered the 
wound site one hour post scrape injury and were spread out over the entire wound area by six 
hours.  Microglia covered the foreign body, in this case a stainless steel microwire, six hours 
after placement and remained there up to 14 days.  Astrocytes began to form a glial scar over the 
microglial covered wire seven to ten days after placement (Figure 6) (Polikov et al., 2006).  
Polikov's results did not correlate with literature from in vivo studies.  Neurons, in vivo, become 
depleted around the recording electrode, leading to a degradation of signal strength and failure of 
the implant.  They concluded ten days in culture was not long enough to witness results typically 
found four to six weeks in vivo (Polikov et al., 2006).   
 
Figure 6. (A-C) Glial scarring on microwire after ten days in culture.  (B-C) Fluorescent labeling of 
nuclei with DAPI (blue), astrocytes with GFAP (green), and microglia with OX-42 (red). (C) Higher 
magnification of image (B) (Polikov et al., 2006).   
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2.3 The Extracellular Matrix of the Central Nervous System 
In 1971, the CNS ECM was first described by Tani and Ametani (Zimmermann and 
Dours-Zimmermann, 2008).  They found that the CNS ECM is composed of numerous proteins 
and polysaccharides secreted from local cells and organized closely into a meshwork (Bruce 
Alberts, 2008).  A specialized sheet-like ECM, known as the basement membrane, is primarily 
composed of collagen type IV, laminin, heparin sulfate proteogylcan and other glycoproteins 
(Yonezawa et al., 2010).  The basement membrane provides mechanical support, separates 
tissues into different compartments, influences cells phenotypes, and acts as a selective 
molecular sieve (Yonezawa et al., 2010).  The basement membrane in the CNS surrounds blood 
vessels and is beneath the pia mater and choroid plexus (Yonezawa et al., 2010).   
The extracellular space in the mature CNS is condensed to 20% of the total volume 
(Rauch, 2007).   Studies have shown that in a healthy adult brain, commonly found ECM 
proteins, such as fibronectin and collagen are scarce beneath the blood brain barrier and choroid 
plexus (Tate et al., 2007; Zimmermann and Dours-Zimmermann, 2008).  In the healthy adult 
brain, fibronectin is limited to the meninges, choroids plexus and vascular basement membrane 
(Tate et al., 2007).  However, fibronectin does play a crucial role in neural development; it 
promotes cell survival, migration, neurite outgrowth and synapse formation (Tate et al., 2007; 
Tate et al., 2009).  Furthermore, when brain tissue damage occurs, fibronectin is found to be 
increased, most likely entering through the injured blood brain barrier  (Tate et al., 2007).  It has 
been shown that fibronectin has a reparative role, similar to that found in wound healing.  It has 
been reported that the protein triggers anti-apoptotic cascades in neurons and is beneficial after 
brain ischemia (Tate et al., 2007; Tate et al., 2009).  Tate et al showed that fibronectin in the 
injured brain serves to protect against cell death which correlates with neurological function 
19 
 
 
(Tate et al., 2007).  The binding of fibronectin to microglial cells has been shown to elevate their 
adhesion, migration and proliferation (Mayeed et al., 2009; Tate et al., 2007; Thanawala et al., 
2007).  It has been shown that the secretion of fibronectin from microglia mediates the adhesion 
of microglia to synthetic materials used in neural electrode design (Mayeed et al., 2009; 
Thanawala et al., 2007).  Moreover, activated microglia have an increased expression of α4β1, 
α5β1, and Mac-1 integrins that bind to fibronectin, which may promote the recruitment of 
microglia to the injury site (Mian et al., 2007; Tate et al., 2007).  The binding of microglia to 
fibronectin will result in the increased production of anti-inflammatory cytokine transforming 
growth factor β (TGF-β) and nerve growth factor, which coherently will increase the production 
of neuroprotective and neurotrophic molecules (Hermanns et al., 2006).  TGF-β is a primary 
regulatory factor in connective tissue and wound healing process; TGF-β1 is immediately 
released after injury, controlling the inflammatory and neuronal response, while TGF-β2 is 
expressed from astrocytes, endothelial cells, and macrophages more slowly, regulating the 
glial/collagenous scarring (Berdichevsky et al., 2010; Hermanns et al., 2006; Klapka and Muller, 
2006).  When TGF-β is released, there will be an increase in fibroblast proliferation, increased 
ECM production, and decreased ECM degradation (Berdichevsky et al., 2010; Hermanns et al., 
2006).  Furthermore, the release of TGF-β results in the transcription of connective tissue growth 
factor (CTGF) gene, which is a mitogen and chemoattractant stimulating collagen and 
fibronectin synthesis in fibroblasts (Figure 7) (Hermanns et al., 2006).   Studies have revealed 
that following injuries to the CNS, a wound healing scar mainly composed of collagen type IV 
and fibronectin is formed in the lesion core surrounded by a glial scar around the parenchyma 
(Figure 8) (Hermanns et al., 2006; Klapka and Muller, 2006).  It is thought that the rupture of the 
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dura allows for the entrance of non-neural meningeal and inflammatory cells to invade the CNS 
lesions (Klapka and Muller, 2006).  Endothelial cells and astrocytes have been shown to express 
collagen type IV after injury (Hermanns et al., 2006).   
 
 
Figure 7. Schematic of TGFb release resulting in a scar tissue composed of ECM proteins (Hermanns et 
al., 2006).   
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Figure 8.  Immunostaining at seven day post injury in adult rat spinal cord of (A) and (C) collagen type 
IV stain and (B) and (D) GFAP (Klapka and Muller, 2006).   
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2.3.1Fibronectin  
Fibronectin is a glycoprotein that is made up of two similar disulfide-linked subunits, 
each with a molecular mass of 250-280 kD and covalently linked by disulfide bonds near their C-
termini (Humphries et al., 1989; Pankov and Yamada, 2002).   There are three repeating subunits 
that make up each monomer; 12 type I repeats, 2 type II repeats, and 15-17 type III repeats 
(Pankov and Yamada, 2002).  Type I repeats contain 40 amino-acids and 2 disulfide bonds, type 
II have 60 amino-acids and two intrachain disulfide bonds, and type III are 90 amino-acids long 
without any disulfide bonds (Figure 9) (Pankov and Yamada, 2002).  Although there is only one 
fibronectin gene, it has evolved from numerous exon splicing, resulting in over 20 known 
variants of human fibronectin (Bruce Alberts, 2008; Pankov and Yamada, 2002).  There are two 
types of fibronectin, depending on its solubility; plasma fibronectin, which is synthesized in the 
liver and found in the plasma and other soluble parts of the body, and insoluble cellular 
fibronectin,  produced by numerous cell types and found in the extracellular matrix (Pankov and 
Yamada, 2002).  Plasma fibronectin remains in a closed, nonactive form circulating in the blood, 
while fibronectin on the cell surface, can polymerize and form large disulfide-linked complexes 
(Humphries et al., 1989; Pankov and Yamada, 2002).  Fibronectin has many binding domains, it 
serves as a ligand for many integrins, linking the ECM to intracellular cytoskeletons and 
contributes to organizing the ECM (Bruce Alberts, 2008; Pankov and Yamada, 2002).  The best 
known integrin-recognition sequence is the Arginine-Glycine-Aspartic acid (RGD) sequence, 
located in the type III10 repeat which binds to the α5β1 integrin (Bruce Alberts, 2008; Hocking et 
al., 1996; Pankov and Yamada, 2002).  Fibronectin fibrillogenesis, or fibronectin matrix 
assembly, is tightly regulated process of creating and depositing fibronectin fibrils into the ECM.  
A critical step during the process of fibrillogenesis is the crosslinking of fibronectin dimers to 
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one another at the disulfide bonds; this process forms the fibrils and aggregates that are deposited 
in the ECM (Bruce Alberts, 2008; Pankov and Yamada, 2002).  Some of these self -binding sites 
are exposed, while others are cryptic and are only accessible after conformational changes 
initiated by cell-driven mechanical stretching (Bruce Alberts, 2008; Pankov and Yamada, 2002).      
 
Figure 9. Structure of fibronectin dimer (left) two of the type III repeats with the RGD sequence (right) 
(Kane et al., 2011).   
 
2.3.2 Collagen 
Collagen, a fibrous protein secreted abundantly in connective tissue cells, is the most 
abundant protein in mammals, making up 25% of the total protein mass (Bruce Alberts, 2008).  
Collagen is made up of three α chains, each one 1000 amino acids long, that are wound together 
into a ropelike, stiff strand.  Collagen is rich in proline and glycine; proline stabilize the helical 
conformation in each α chain while glycine is spaced at every third amino acid residue 
throughout the middle of the α chain (Figure 10) (Bruce Alberts, 2008).  Collagen is arranged as 
a left-handed helix with three amino acids at every turn and glycine every third amino acid; 
triple-helices contain many triplet G-X-Y sequences, with X and Y being any amino acid, but 
usually X is proline and Y is hydroxyproline (Bruce Alberts, 2008).  There are 42 different 
24 
 
 
human genes that code for collagen α chains, making 40 known types of collagen molecules; 
examples include type I collagen which is prominent in skin and bone and type IV collagen a 
major part of the basal lamina (Bruce Alberts, 2008).  Collagen has a unique characteristic 
known as self assembly.  Once collagen triple-stranded helical rod is secreted into the 
extracellular space, the collagen molecules self assemble into higher order polymers called fibrils 
(10-300 nm in diameter and hundreds of micrometers long) (Bruce Alberts, 2008).  Collagen 
fibrils aggregate into large, cable-like bundles called collagen fibers, which are several 
micrometers in diameter.  Collagen type IV triple helices are about 400 nm in length and self 
assemble to form the backbone of the basement membrane (Klapka and Muller, 2006).  Collagen 
type IV is highly insoluble due to its disulfide and/or lysine aldehyde-derived cross-links 
(Klapka and Muller, 2006).   
 
Figure 10.  Structure of collagen (a) one α chain (b) collagen triple-stranded helix (Kane et al., 2011).   
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CHAPTER 3 
3.1 Neural Electrodes 
The use of electrosimulation of neural tissues goes back to 2500BC when Ancient 
Egyptians used the electrical shock from electrical catfish as a method of pain relief (Kotov et 
al., 2009).  Since then, researchers have been developing neuroprosthetic devices that use 
microelectrode arrays to stimulate nerve cells.  Current devices are based on electrical field-
effect stimulation of functional neural elements to treat different diseases or disorders.  These 
devices may provide a viable treatment for degenerative diseases of the CNS and spinal cord 
injury. The Food and Drug Administration approved the use of neural electrodes in adults in 
1985; as of 2005, there were over 150,000 people with a cochlear implant (Kotov et al., 2009).  
Some of the other successful advancements made are the brain stimulations used to treat 
Parkinson’s disease (Szarowski et al., 2003), epilepsy, tinnitus and retinal vision prosthesis 
(Cogan, 2008; Elfar et al., 2009; MA Howard, December 16, 1997).  The use of microfabrication 
technology has helped fabricate devices ranging from 10 to 100s of micrometers, therefore 
allowing the target of precise regions in the brain (Szarowski et al., 2003).     
There are two main subcategories of cortical neural prosthetics, stimulating and 
recording.  Stimulating neural electrodes are used for Parkinson’s disease treatment and restoring 
hearing (Zhong and Bellamkonda, 2008).  Recording devices are also known as brain-computer 
interfaces and are used to help paraplegics control a wheelchair or prosthetic limb through 
thought by reading signals from an array of neurons and translating them into action (Zhong and 
Bellamkonda, 2008).  Recent developments in microelectrode arrays include microwires, silicon 
micromachined microprobes (SMM) and polymer substrate probes; most commonly used are 
microwires and SMMs for their ease of process and fabrication (Zhong and Bellamkonda, 2008).   
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3.1.1 Microwires 
Microwires were the first used chronic recording electrodes.  They are fine wires with 25-
50 μm diameter and 8 mm in length (Polikov et al., 2005).  They are made from conducting 
metals, such as platinum, gold, tungsten, iridium, stainless steel and are insulated with non-
cytotoxic Teflon or polyamide (Figure 11) (Zhong and Bellamkonda, 2008).  The tip of the wire 
is not coated with an insulator therefore able to receive electronic signals from neurons (Polikov 
et al., 2005).   These wires are soldered to a small connector in an array and glued to the skull to 
allow for greater prosthetic control (Zhong and Bellamkonda, 2008).  Microwires are easier to 
fabricate, can enter deeper into the brain tissue and have a higher quality of recordings with 
lower impedance compared to silicon based electrodes (Polikov et al., 2005). However, they 
have been typically found to begin to lose signal within 5 weeks after implantation (Williams et 
al., 1999; Zhong and Bellamkonda, 2008).  If the cortical surface moves after surgery, the 
electrode tips may either move to another cortical layer or move deep into the white matter, 
therefore failing to record from the desired neurons (Zhong and Bellamkonda, 2008).   
 
Figure 11.  Microwires made of Teflon coated stainless steel (Khan et al., 2005; Polikov et al., 2005). 
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3.1.2 Silicon Micromachined Microprobes 
Silicon micromachined microprobes (SMM) offer many advantages to microwire 
electrodes.  The silicon photolithography process allows for smaller and higher electrode count 
arrays.  This allows for more control over size, shape, texture, and spacing of the electrode, and 
for the ability to have multiple recording sites in a single electrode shank (Polikov et al., 2005; 
Zhong and Bellamkonda, 2008).  There are two widely used SMMs, the Michigan probe and the 
Utah Electrode Array (UEA) (Figure 12).  The Michigan Probe was developed at the University 
of Michigan Center for Neural Communication Technology.  Michigan probes are composed of 
planar arrays of electrode shanks.  These shanks are prepared from a single, thin, sheet of silicon.  
Shanks are typically, 15 μm thick, 100-500 μm wide, and range in length from 2 mm to 1 cm. 
Multiple recording sites are placed all along the top and bottom of the probe at user defined 
locations, rendering them to have better access to neurons (Polikov et al., 2005).    Moreover, the 
electrodes will be able to be placed at multiple cortical depths for complete control of recording 
locations and depths, ideal for extracellular recordings (Zhong and Bellamkonda, 2008).  
Compared to the microwire electrodes, advantages of the Michigan probes include ability to 
fabricate batches at a time, reproducibility of size, shape and relative electrode locations, 
composition of high-density recording sites, and ability to incorporate circuits directly onto the 
probe (Zhong and Bellamkonda, 2008).  Disadvantages include high electrode impedance, 
fragility due to planar design, therefore making them difficult to handle, post-process and further 
modify (Zhong and Bellamkonda, 2008).   Currently, Michigan probes are being used in 
diagnostic and therapeutic neurological applications (Mian et al., 2005).   
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The UEA was developed at the University of Utah Center for Neural Interfaces and has 
been in use for over 20 years, but clinically only since 2004 (Mian et al., 2005).  A single block 
of silicon is etched, doped, and heat treated to form the 3D array of needle-like electrodes with 
recording tips.  The UEA can have either 25 or 100 shanks and varies in shape.  Each shank is 
1.5mm in length and ranges from 100 μm at its base to less than 1 μm at the tip (Polikov et al., 
2005).  Both systems require an insulating layer to protect the electrode from unwanted electrical 
signals.  Teflon or S-isonel coatings have been successfully used with microwire electrodes.  
Epoxylite resins and plasma-deposited diamond-like carbon (DLC) have also had success.  
Polyamide is most commonly used to coat silicon based devices.  
 
Figure 12. (A) Michigan electrode (B) Utah electrode (Harris et al., 1997; Kam et al., 2002; Polikov et 
al., 2005). 
 
3.1.3 Clinical Use of Neural Prostheses 
There has been a great deal of success in neural prostheses research over the last 35 year 
(Mian et al., 2005).  Currently, over 200,000 devices are implanted into patients (Table 1) 
(Gobbels et al., 2010; Mian et al., 2005).  The majority of these devices are either implanted into 
the spinal cord or a peripheral nerve.  To date, there are limited microelectrodes that are used to 
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penetrate through the human cortex, otherwise known as, "brain-computer-interfaces" (BCI) 
(Mian et al., 2005).  In fact, the first clinical use of the UEA was in 2004.  At this point it has 
been commercialized to Cyberkinietics, Inc. (Foxborough, NJ, USA).  This electrode was 
implanted in human subjects suffering from high spinal cord lesion (C3).  These patients can 
now communicate through these neural prosthetic interfaces, at 20 letters per minute (Mian et al., 
2005).  In recent years, there have been a growing number of clinical trials using BCI to 
circumvent motor deficits (Grundke-Iqbal et al., 1981; H. Makamba, 2003; Samuel K. Sia, 2003; 
T. C. Merkel, 2000).  However, their widespread clinical implantation is currently impeded by 
the difficulties in maintaining stable long-term recordings (Grundke-Iqbal et al., 1981).   
 
 
 
Table 1. Summary of fully implanted neural prostheses with more than 1,000 implanted systems 
(Gobbels et al., 2010; Mian et al., 2005). 
Application 
Number of 
Implants Manufacturers 
Spinal cord stimulator to treat intractable 
pain and motor disorders >130,000 
Advanced Neuromodulation Systems, 
USA; Medtronic, USA 
Auditory nerve stimulator to restore hearing 
(cochlear implant) >55,000 
Advanced Bionics, USA; AllHear, USA; 
Cochlear, Australia; MED-EL, Austria; 
MXM lab, France 
Deep brain stimulator for tremor, 
Parkinson's disease and pain >20,000 Medtronic, USA 
Vagal nerve stimulator to treat intractable 
epilepsy >17,000 Cyberonics, USA 
Sacral nerve stimulator for urinary urge 
incontinence, urinary retention, pelvic pain 
and faecal incontinence 
>10,000 Medtronic, USA 
Sacral nerve stimulator for bladder 
emptying >2500 Finetech Medical, UK 
Phrenic Nerve stimulator for respiration >1600 Avery Laboratories, USA; Atrotech, Finland; MedImplant, Austria 
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3.2 Neural Electrode Biomaterials 
 
Neural electrodes are expected to function for the lifetime of the patient (Zhong and 
Bellamkonda, 2008).  Customary biocompatible, corrosion-resistive materials are used for 
electrodes, including platinum, silicon and conducting polymers (Kotov et al., 2009).  Platinum 
is one of the most commonly used materials in medical practice (Kotov et al., 2009).  Platinum is 
used as stimulating/recording electrodes for it excellent conductivity (Polikov et al., 2005).  
Moreover, it is resistant to corrosion and has charge storage capacities in the range of 300-
350mC cm-2.  However, there have been several studies that have found cytotoxic effects from 
SU-8 (De Boeck et al., 2003; Vernekar et al., 2009), silicon (Kotzar et al., 2002; Szarowski et al., 
2003) and platinum (Griffith and Humphrey, 2006) cultured with neuronal cells or implanted in 
vivo.  In a study done by Griffith et al with Rhesus macaque, glial scarring was found around 
platinum wires implanted into the motor cortex for periods up three years (Griffith and 
Humphrey, 2006).   
SU-8 is a highly cross-linked, negative, near-ultraviolet (UV; 350-400nm) epoxy based 
photoresist that allows manufacturers to make high-aspect ratio thick microelectromechanical 
systems (MEMS) structures (Hopcroft et al., 2005; Vernekar et al., 2009).  SU-8 is a commonly 
used material for bioMEMS and lab-on-a-chip devices.  Advantageous of SU8 include its has 
dielectric properties, transparency to visible light, low Young’s modulus (below ~5 Gpa), and 
low cost, (Hopcroft et al., 2005; Voskerician et al., 2003).  Moreover, it is used because of its 
mechanical strength, chemical resistance, and simplicity in fabrication of a high aspect ratio 
structure.  These properties suggest that SU-8 will have strong electrical and optical recording, 
which make it a compatible neuron-based device (Wu et al., 2006).     
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Conflicting data has been reported on the biocompatibility of SU-8.  Kotzar et al 
investigated the biocompatibility of numerous bioMEMS materials, including silicon and SU-8.  
They found that these materials were not cytotoxic to mouse fibroblasts in vitro.  Subsequently, 
they performed a study using rabbit muscle implantations which lead them to classify these 
materials as non-irritants.  Furthermore, studies performed by Kisaalita's et al concluded that SU-
8 microstructures are viable platforms for cell culturing systems for cell-based biosensing against 
drugs and promoting human neuroblastoma cells' resting membrane potential (Wang et al., 2009; 
Wu et al., 2006).   
 There have been several studies revealing contrary results with respect to the 
cytotoxicity with SU-8, thus rendering it a controversial material for biomedical purposes 
(Vernekar et al., 2009; Wu et al., 2006).  It appears that the specific formula of SU-8 utilized in 
these experiments differ and may be the reason for the varying cell responses.  When conducting 
aqueous physiochemical tests, Kotzar et al found that Si3N4 and SU-8 leached detectable 
nonvolatile residues (Kotzar et al., 2002; Ni et al., 2009).   Vernekar et al examined primary 
neuronsfrom rats on various surface treatments of SU-8 for 21 days in vitro (Vernekar et al., 
2009).  Neurons had poor adhesion to the SU-8 surfaces and less than 10% of neurons survived 
when cultured adjacent to or on the SU-8 substrates (Vernekar et al., 2009).  Moreover, they 
found toxins such as fluorine and antimony leaching from the SU-8 2000.  SU8 2015 contains a 
faster drying, more polar solvent, cyclopentenone, compared to the original formula (SU-8-2000) 
which used butyrolactone (Vernekar et al., 2009).  It was concluded that the current formulas of 
SU-8/SU-8 2000 are cytotoxic to primary neurons, thus rendering them incompatible (Vernekar 
et al., 2009). 
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Methods such as heat treatment, isopropanol sonication, parylene coating and oxygen 
plasma treatment all improved the cytocompatibility of SU-8.  It was found that reusing the SU-8 
2000 samples removed some of these toxic agents through passive diffusion.  Therefore, 
indicating a possibility of detoxifying the SU-8 2000 through diffusion techniques.   
Poly methyl methacrylate, (PMMA)  and polysytrene are both considered biocompatible 
materials commonly used as substrates for mammalian cell culture (Ni et al., 2009).  PMMA has 
been used for medical applications for a number of years for its excellent tissue 
compatibility(Frazer et al., 2005).  PMMA is a polymer that has been often used in numerous 
medical devices and more recently been employed for the production of MEMS for medical 
applications (bioMEMS/bioNEMS) (Bhushan, 2008; Frazer et al., 2005; Kotzar et al., 2002).  
Characteristics of PMMA include its excellent tissue compatibility, ease of polymer 
manipulation, strength, availability, inexpensiveness, radiolucency, low thermal and electrical 
conductance and weight.  Negative features of PMMA include its relative low surface energy 
and tremendous release of heat during polymerization, which may cause protein denaturation and 
tissue damage (Frazer et al., 2005).  Several groups have shown good growth rates for dorsal root 
ganglion neurons cultured on PMMA (Cogan et al., 2006; Song and Uhrich, 2007).  Moreover, 
these groups stated they used PMMA as their substrate because of its isotropic properties, the 
fact that it is a well-characterized polymer for Nano-Imprint Lithography (NIL) in their 
laboratory.   
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CHAPTER 4 
4.1Nanopatterning 
Current approaches towards inhibiting the initiation of glial scarring range from altering 
the geometry, roughness, size, shape and materials of the device (Grill et al., 2009; Kotov et al., 
2009; Kotzar et al., 2002; Szarowski et al., 2003).    An array of design strategies have been 
targeted toward minimizing failure of implanted microelectrodes by minimizing the chronic glial 
scar around the microelectrode under chronic conditions.   These approaches have included 
developing novel implant materials, shape, size, and rigidity.   The speed of implantation, use of 
bioactive coatings, and repositioning of the device post implantation have also been studied to 
improve biocompatibility (Stice and Muthuswamy, 2009).  In order to properly design a 
successful neural electrode, the understanding of the cellular environment is mandatory.   
In vivo conditions comprise of cells living in the ECM meshwork with a three-
dimensional and high aspect ratio topographical textures (Millet et al., 2010; Wu et al., 2006).  
The 3D environment allows cells to have topographical cues which will allow them to 
differentiate and perform their specific functions.  Moreover, the first interaction that a protein 
has with the biomaterial is what influences the cellular response.  Properties such as the 
chemistry, surface charge, and topography of a material are major factors in protein adsorption, 
of which consequently effect the cell reaction as well  (Kriparamanan et al., 2006).  The 
objective of altering the surface of material by adding a nanoscale surface roughness lies in the 
understanding that the in vivo environment is not smooth.  Atomic force microscopy (AFM) has 
been used to measure the topographic structure of numerous basement membranes 
(Kriparamanan et al., 2006).  These studies have shown that a material that can mimic the 
nanotopography of the natural environment in vivo will consequently result in an improved 
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biocompatible response (Curtis et al., 2004; Ding et al., 2010; Kotov et al., 2009; Millet et al., 
2010; Zervantonakis et al., 2011).  Nanotopography has been shown to affect the cells’ 
morphology, alignment, adhesion, proliferation, gene expression profiles and even prevent 
biofouling and contamination on the material’s surface(Kriparamanan et al., 2006).  Topography 
affects gene expression and protein production, such as cytokines, growth factors, signaling 
molecules, and cytoskeleton linked molecules (Kriparamanan et al., 2006).  Therefore, just as the 
chemical composition of a material alters the cellular response, as does the size of the 
nanostructure on the substrate.  Researchers in Scotland have done extensive work in surface 
topography and fibroblasts.  They have found that fibroblasts will adhere to surfaces with a 
height range of 20-70nm, but will not attach well to larger or smaller surfaces of the same 
material (Curtis, 2005; Curtis et al., 2004; Das et al., 2008; Fok-Seang et al., 1998).  In another 
study they found that fibroblast adhesion is enhanced at cliff edge features, but diminished at pits 
and pillars (Fok-Seang et al., 1998).  They concluded that cellular adhesion is affected by surface 
features (Fok-Seang et al., 1998).  This group also studied the cytoskeleton of fibroblasts on 
microgrooved surfaces and confirmed an earlier theory that, “cells react to topography primarily 
at lines of discontinuity in the substratum by actin nucleation” (Muir et al., 1998).  They 
concluded that the aggregation of actin along groove/ridge boundaries is a primary driving event 
in determining fibroblast orientation on microgrooved substrata (Muir et al., 1998).  Effects of 
microgrooves on fibroblast gene expression were observed in a later study (O'Keefe et al., 2001).  
The results showed many initial gene changes and also down-regulation of gene response with 
time (O'Keefe et al., 2001). This was thought to happen due to the deformation in the cell and 
nucleus morphology (O'Keefe et al., 2001). 
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Cell type also appears to play a role in reaction to the material topography (Kriparamanan 
et al., 2006).  This cell-specific response can be used when customizing novel topography for 
specific devices.  For example, it may be important for one cell type to adhere and spread on a 
surface while not for another cell type (Kriparamanan et al., 2006).  It has been shown that 
fibroblasts show a decrease in cell adhesion on 50-100nm sized etching, whereas endothelial 
cells adhere and proliferate on 50-500nm sized etched nanostructures (Chung et al., 2010; Chung 
et al., 2009; Sudo et al., 2009).  Dalby et al studied the effects of polymer demixed island 
topography with a 95-nm Z axis on endothelial and fibroblast cells (Bruder et al., 2007).  They 
found that endothelial cells exposed to the  topography had more of a curved morphology, 
similar to the vascular endothelium found in vivo (Bruder et al., 2007).   Meanwhile, fibroblasts 
exposed to these same islands had more of a rounded morphology and poorly shaped 
cytoskeleton (Bruder et al., 2007).  These results suggested that the cells had more of a 
phenotypically correct morphology when exposed to the nanoscale features (Bruder et al., 2007; 
Dalby et al., 2004; Das et al., 2008; Kriparamanan et al., 2006).   
The mechanism involved with the cellular response to a nanopatterned surface is not well 
understood.  It is thought that the effects of the surface topography directly influence the cell 
response, or indirectly effect the cell responses through the affects they have on the adsorption of 
proteins (Kriparamanan et al., 2006).  Nanotopography has been shown to alter protein 
adsorption, as it has been shown that different proteins respond differently to the nanopatterned 
surfaces (Kriparamanan et al., 2006).  The range for optimal protein adsorption on a 
nanopatterned surface is found to be very narrow (Kriparamanan et al., 2006).  Studies have 
shown low randomly oriented protein adsorption on a 4 nm height, but high adsorption of 
defined orientation proteins on 1-2 nm high nanostructures (Kriparamanan et al., 2006).   Cell 
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alignment onto the surface begins soon after the cells adhere to the surface and it is very 
dependent on the cell type.  The substrate topography affects the alignment of the actin filaments 
and the focal adhesion structures, therefore altering the cell morphology, adhesion, and function 
(Kriparamanan et al., 2006).  Cell alignment generally means the polarization and elongation of 
the cells in the direction of the nanogrooves.  For example, when fibroblasts are seeded onto a 
nanostructured surface, the first event that takes place is the cytoskeleton arrangement (Curtis, 
2005; Curtis et al., 2004; Das et al., 2008; Fok-Seang et al., 1998).   Within the first five minutes 
post seeding, the actin aggregation occurred then within 20 minutes there microtubules align 
(Curtis, 2005; Curtis et al., 2004; Das et al., 2008; Fok-Seang et al., 1998).  Another study 
showed that human corneal epithelieal cells align in the direction of 70nm wide grooves and 
ridges; however, when seeded onto a flat surface, they did not have a specific orientation 
(Teixeira et al., 2003).    
Topographic effects have been investigated extensively for silicon and titanium and to a 
lesser extent PMMA (Kotov et al., 2009).  Photolithography is the traditional method for 
modifying the surface topography of substrates, however, this technique is limited by the 
diffraction limit of light and therefore cannot produce structures on a nano-sized level (Blattler et 
al., 2006).  Over the years, new techniques have been developed to create reproducible, high 
quality patterns at a low cost.  These techniques include, extreme ultraviolent interference 
lithography, soft-lithographic techniques (i.e. replica molding and  microcontact printing, 
nanoimprint lithography (NIL), nanosphere lithography (colloid lithography or colloidal block-
copolymer micelle lithography), and nanostencil technique (Blattler et al., 2006; Das et al., 2008; 
Ding et al., 2010; Kriparamanan et al., 2006).  Most of these techniques require a mask or master 
that contains the pattern to be printed; this mask may be reused many times.  Optical 
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nanolithography is the most widely used and best established lithography technique available 
(Blattler et al., 2006).  This technique uses ultraviolet (UV) light to create micropatterns thru an 
etching or lift-off process.  In order to create patterns on a nanoscale level, the extreme 
ultraviolet interference lithography (EUV-IL) technique is used(Blattler et al., 2006).  This 
method generates patterns with high fidelity, which are highly reproducible and can cover an 
area as large as 3x3mm2.  Microcontact printing uses a stamp made out of  a soft, flexible 
polymer, therefore allowing application to a rough or curved substrate (Blattler et al., 2006).  
NIL is cheap and fast, so it can produce many test surfaces quickly (Cogan et al., 2006).  It is 
easy to produce patterns smaller than 10nm because, the resolutions of NIL samples are not 
dependent on diffraction or scattering.   
4.2 Nanopatterning Effect on Brain Cells 
As stated earlier, the proximity of the neuron to the electrode determines the strength of 
the signal captured, therefore it is imperative to find methods to attract, adhere, and preserve 
neurons near recording sites.  There are numerous methods for enhancing neuronal attachment, 
including the coating of cell adhesion proteins, such as collagen and fibronectin, or even 
polypeptides such as RGD.  Ignatius et al found that coating cover slips with poly-d-lysine and 
laminin, neurons attached, spread and grew much better compared to uncoated surfaces (John et 
al., 2001; Polikov et al., 2005).  Furthermore, it has been found that regardless of the surface 
underneath; neurons will grow on top of astrocyte monolayers in culture (Liberto et al., 2004; 
Polikov et al., 2005; Theil et al., 2005).  Neuronal processes have been found to extend along the 
tracks provided by the astrocytes.  Therefore, in order to potentially block the negative 
components found in the glial cell response, astrocytes would need to be attracted and adhered 
onto the electrode surface (Duffy et al., 2000; Polikov et al., 2005).  Hence, the goal of neural 
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electrode fabrication is to find a material surface that will maintain neurons proximity to the 
recording surface, minimize astrogliosis, and eliminate chronic microglial activation (Polikov et 
al., 2005).     
Nanofabrication of nanoelectrode arrays is being pursued in the field of neuronal 
electrophysiology in order to increase sampling capabilities (Blattler et al., 2006).  By having a 
larger electrode surface area, through micro/nano-patterning, the electrode will be more 
accessible to ions, therefore, greatly increasing the capacitative component (Kotov et al., 2009).  
Neural cell function, such as neurite alignment, has been shown to be affected by the topography 
of materials.  Table 2 summarizes selected literature studying the effect surface topography has 
on neural cells.   Micropattterning has been shown to guide neuronal cell growth in neuronal 
implants and in vitro neural networks for tissue engineering applications (Blattler et al., 2006).   
Nanofabrication has promise to better understand cell behavior by mimicking the nano-world 
around the cell created by the nanotopographies of the ECM and the nanochemistry that 
composes the cell membrane (Blattler et al., 2006).  It is the ability of a nanomaterial to mimic 
the roughness of natural tissue that is so interesting when designing optimal implants for the 
central nervous tissue.  In fact, studies have shown that select proteins (i.e. fibronectin and 
vitronectin) adsorb more on nanomaterials compared to smooth materials of the same chemistry.  
This protein adsorption is the initiator of better cell adhesion, alignment, and outgrowth of 
neurites (Rose et al., 1985).  It has been proposed that the uncontrolled, non-specific interactions 
between biological molecules and an implant are the cause for device failure.  The rejection of an 
implant due to immune reactions, the short circulation time of drug-delivery particles, and the 
false response of biosensors are often caused by the non-specific adsorption of proteins (Blattler 
et al., 2006).  Moreover, it has been shown that the proteins adsorbed to nanomaterial surfaces 
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may expose more amino acid binding sequences than proteins adsorbed to conventional 
materials, consequently allowing for greater cell adhesion.  (John et al., 1999; Rose et al., 1985).  
Webster et al found that when vitronectin is adsorbed onto nanophase alumina, there was 
protein unfolding, therefore exposing adhesion binding sites, such as the Arginine-Glycine-
Aspartic Acid-Serine (RGDS) sequence (John et al., 1999; Rose et al., 1985) .  In another study, 
they showed that there was less adhesion and proliferation of astrocytes and fibroblasts on 
carbon nanofibers compared to carbon fibers with diameters not in the nanoscale (Petrossians et 
al., 2011; Rose et al., 1985).  Studies done by Shain et al found that astrocytes prefer to grow and 
adhere onto patterned surfaces of varying dimensions over smooth silicon surfaces in vitro 
(Kriparamanan et al., 2006; Szarowski et al., 2003).  They used photolithography and 
microcontact printing to deposit hydrophobic and hydrophilic self assembling monolayers of 
organosilanes. Seil et al studied the astrocyte adhesion and proliferation on zinc oxide 
nanoparticle polyurethane composites.  They found that there was a significant decrease in 
astrocyte adhesion and proliferation when there were more zinc oxide nanoparticles on the 
surface (Rose et al., 1985).  This is believed to occur for several reasons.  First, the nanoscale 
surface features better imitate the nanoscale protein rich environment of the ECM found in vivo.  
Second, the surface area of the nanoscale roughness samples is much larger, therefore allowing 
for more interaction between the cells and proteins on the surface.  Third, nanomaterials have 
more of a surface energy than flat surface due to their increase in grain boundaries.  This increase 
of surface energy is thought to not only increase the amount of protein adsorption, but the 
conformation of the proteins adsorbed as well (Rose et al., 1985).   
Johansson et al found that axons can be guided by imprinted nanosized patterns, down to 
100nm   and that axons grew on top of the ridges rather than inside of the grooves of the pattern 
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(Cogan et al., 2006).  They correlated this with previous studies that showed cells like to grow 
uphill, negative curvature, over downhill, positive curvature (Cogan et al., 2006).  In the study 
performed by Wu et al, they used 3-D structures made from SU-8 with depths of 100um or 
aspect ratios greater than one.  They found that they could promote SH-SY5Y human 
neuroblastoma cells to maintain a resting membrane potential on a 3-D microwell network 
meshwork compared to flat SU-8 substrates.  Their findings suggest that cellular function may be 
controlled through topography engineering (Wu et al., 2006).  They used the following 
dimensions: 50-um wells (diameter) with center-to-center spacing of 55-um, 100-um wells with 
a center-to-center spacing of 110-um, 100-um wells with center-to-center spacing of 190-um 
connected by a 10-um wide microchannels all having 100-um depths.  These dimensions were 
used because even the smallest diameter was large enough to have the cells easily fit during 
plating.   They found that compared to flat surfaces, cells on the patterned SU8 exhibited a cell 
resting membrane potential.   
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Table 2. Neuronal Cells on Patterned Surfaces 
Material Fabrication Technique 
Feature 
Type 
Width/ 
diameter 
Depth/ 
height 
Other 
Size Cell Type Effects 
polystyrene 
Nd:YAG 
polarized laser 
radiation at 
266nm 
ridge/ groove  30-40nm 
210nm 
(period) C6 glioma  
Ordered and continous 
nanostructures can pattern cells, 
guide cell alignment, and orient 
growth along definite directions 
(Zhu, Zhang et al. 2004).   
polystyrene 
photolithography 
and solvent 
casting 
ridge/ groove 10um 3um 20um (pitch) 
rat Type-1 
astrocytes 
(primary) 
85% of astroglial alignment in the 
direction of the grooves (Recknor, 
Recknor et al. 2004).   
PMMA nanoimprint lithography grooves 100-400nm 300nm 
100-
1600nm 
(spacing) 
adult mouse 
sympathetic 
and sensory 
ganglia 
Axons displayed contact guidance 
on all patterns.  Nerve cell 
processes preferred to grow on 
ridge edges and elevations in the 
patterns rather than in grooves 
(Johansson, Carlberg et al. 2006).  
silicon photolithography  pillars 0.5-2.0um (d) 1.0um 
1.0-5.0um 
(gaps) 
LRM55 
astroglial 
cells 
70% of cells preferred pillars over 
smooth silicon.  Cells made 
contact with the tops of the pillars 
and did not reach the down into 
the spaces between the pillars 
(Turner, Dowell et al. 2000).  
zinc oxide 
(ZnO) 
nanoparticles 
on 
polyurethane 
(PU) 
Mixing PU and 
ZnO 
nanoparticles 
nanoparticles ~60nm (d)   
CRL-2005 rat 
astroctes 
Astrocyte adhesion was reduced on 
ZnO nanoparticles/PU compsites 
compared to pure PU (Seil and 
Webster 2008). 
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Material Fabrication Technique 
Feature 
Type 
Width/ 
diameter 
Depth/ 
height 
Other 
Size Cell Type Effects 
Carbon 
nanofibers 
catalytic and 
chemical vapor 
deposition 
fibers 60-200nm (d)   
CRL-2005 rat 
astroctes 
Decrease in astrocyte adhesion and 
cunction, which may lead to a 
decrease in glial scar tissue 
formation (McKenzie, Waid et al. 
2004).   
silicon 
substrates 
with DETA 
and OTS 
organosilanes 
microcontact 
printing 
arrays of 
hexagonal 
features 
5-50um   
LRM55 
astroglial 
cells 
As feature size increased, cell 
adhesion increased (Kam, Shain et 
al. 1999).   
silicon chemical (HF) etching 
surface 
roughness 
2-810nm 
(Ra)   rat Nigral cells 
Cells survuved for over 5 days with 
normal morphology and expressed 
neuronal TH when grown on 
surfaces with average roughness 
(Ra) from 20-50nm.  Cell 
adherence was adversely affected 
at Ra less than 10nm and greater 
than 70nm (Fan, Cui et al. 2002).   
silicon chemical etching surface roughness 10-250nm   
primary 
cortical 
neurons 
Optimum surface roughness range 
of 20-100nm that promotes cell 
adhesion and longevity (Khan, 
Auner et al. 2005).   
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Material Fabrication Technique 
Feature 
Type 
Width/ 
diameter 
Depth/ 
height 
Other 
Size Cell Type Effects 
gold and 
porous anodic 
alumina 
(PAA) 
electrodeposition 
nanopores 
and 
nanopillars 
nanopillar: 
200nm 
(d); 
nanopore: 
200nm  
nanopillar: 
2um  
nanopillar: 
70nm 
(spacing) 
PC12 
Cells were spatially aware of 
nanoscale structures and 
responded differently to 
nanopores and nanopillars.  Cells 
on nanopores and nanopillars had 
fewer and shorter neurites 
compared to those on smooth 
surfaces.  Cells on nanopores 
developed more and longer 
neurites than those on nanopillars 
(Haq, Anandan et al. 2007).   
silicon photolithography pillars 0.5-2.0um 1um 0.5-5.0um (gaps) 
neurons from 
hippocampi 
rat embryos 
Neuron growth on pillare surfaces 
exhibited alignment to pilar 
geometries with the smallest gap 
sizes.  Neurite lengths were 
significantly longer on pillars with 
the smallest gaps and 2um pillar 
widths (Dowell-Mesfin, Abdul-
Karim et al. 2004).   
PDMS soft lithography gratings 350nm-10um 350nm 
700nm-
20um 
(pitch) 
human 
mesenchymal 
stem cells 
Nanotopography showed a stronger 
effect in enhancing upregulation 
of neuronal marker expression, 
compared to biochemical cues and 
unpatterned surfaces.  Showed 
significance in nanotopography in 
directing differentiation of adult 
stem cells (Yim, Pang et al. 2007).  
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CHAPTER 5 
5.1 Characterization of Astrocyte Reactivity and Gene Expression on Biomaterials for 
Neural Electrodes 
 
It is crucial that materials used for neural electrode devices, intended for long-term in 
vivo purposes, to go through meticulous investigation of biocompatibility requirements.  There is 
a lack of research studying astrocyte reactivity in vitro on multiple materials used for neural 
electrodes.  The current study was designed to investigate the astrocyte proliferation, viability, 
morphology, and gene expression in order to assess the reactive state of the cells on different 
material surfaces.  Although platinum and silicon have been extensively characterized both in 
vivo and in vitro for their biocompatibility with neuronal cells, this study utilized the novel usage 
of PMMA and SU8 in neural electrodes by comparative analysis of materials' biocompatibility.  
5.2 Methodology 
5.2.1 Material Fabrication 
SU-8 samples were fabricated by spincoating SU-8 photoresist (2025). SU-8 was coated 
using the suggested parameters in Microchem website for 1 um thickness, onto silicon wafers. 
Thin film of platinum was deposited on silicon substrate using electron beam evaporation 
(Electron Beam Evaporator-BJD 1800), with titanium as an adhesion promoter and subsequent 
deposition of platinum onto the substrate. Evaporation was performed at a pressure of 1.0 _ 10-7 
Torr, and a rate of 0.5 Å/sec for platinum and 1 Å/sec for titanium. The thickness of the film was 
100nm and 10 nm for platinum and titanium respectively. The wafers were then cut into 1 
cm2pieces. PMMA sheets were cut into 1 cm2 pieces. Polystyrene cover slips were employed as 
a control surface.  Materials were washed with a Ultraomet 2003 Sonic Cleaner (Buehler, Bluff, 
IL) in ethanol, followed by distilled water for 15 minutes in each solvent.  Platinum, silicon and 
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SU-8 samples were autoclaved for 30 minutes at 121oC, before cell seeding all of the samples 
were sterilized under UV light.   
5.2.2 Surface Chemistry Characterization 
Energy-dispersive X-ray spectroscopy (EDX) was used to characterize the elements 
found in SU8.    This technique was used to observe if antimony (Sb), a toxic salt used as a photo 
acid generator in the fabrication process, was present.  To quantify the amount of antimony 
present in SU8, the surface composition of the deposited films was analyzed by X-ray 
photoelectron spectroscopy (XPS) using monochromatic AlKa radiation in a Perkin Elmer model 
S500 XPS Spectrometer.  
5.2.3 Cell Cultures 
This study utilized C6 rat astrocytoma cell line (ATCC, Manassas, VA).  The cells were 
maintained in a F-12K medium supplemented with 10% horse serum, 2.5% fetal bovine serum 
(FBS), and 1% antibiotics-antimycotic. The cells were kept in a humidified incubator with the 
following setting conditions: 90% humidity, 5% CO2 and 37.8oC. The media was changed twice 
a week.  Cells were detached using trypsin and then centrifuged at 1000rpm.  Following which, 
the cells were resuspended in culture media, stained with Trypan blue and counted using a 
hemocytometer.  There were 5000 cells in 100μl droplet of culture media loaded onto each 
sample in a 24 well plate.  Following three hours of incubation at 37oC, 500μl of culture media 
was added to each well.  The culture media was changed twice a week during the study.   
5.2.4 Proliferation Assay 
The methylthiazolyldiphenyl tetrazolium bromide (MTT) colorimetric assay was 
employed to determine the number of cells and the rate at which they proliferated at days 1, 3, 
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and 7 post seeding.  At each time point, 0.5 mg/mL MTT reagent was added to the culture 
medium and reincubated for 5 hours in the dark at 37oC until the yellow MTT was reduced to 
purple formazan crystals.  The culture media was removed carefully, so as to not disturb the 
formazan crystals, and replaced by dimethyl sulfoxide (DMSO), which solubilized the formazan 
crystals and cells. Absorbances were read at 570nm and 650 nm in a microtiter plate reader.  The 
optical densities were calculated by subtracting the 650nm reference wavelength from the 570nm 
absorbance reading.  To measure the approximate number of cells on the given test days, a 
growth curve for C6 cells was also generated by performing a MTT assay on a graded series 
(range from 2,000 to 1,500,000 cells) of cells plated on polystyrene culture dishes. 
 5.2.5 Real Time PCR 
Real time PCR was used to measure gene expression from the different samples relative 
to the control surface (polystyrene samples).  The total RNA from the samples was extracted on 
days 3 and 7 post seeding with Trizol (Invitrogen, Carlsbad, CA) following the manufacturer’s 
protocol.  The RNA concentration and purity was determined using a spectrophotometer through 
UV absorbance at 260nm and 280nm.  Reverse transcriptase using the oligo(dT)20 primer 
converted the mRNA to a cDNA template using a thermal cycler (Mastercycler Gradient, 
Eppendorf, Hauppauge, NY).  For PCR analysis, we used cDNA equivalent to 50ng of total 
RNA.  Specific primer pairs (Table 3) for proliferation, mitogen-activated protein kinase kinase 
1 (MAP2K1) and astrocyte activation, glial fibrillary acidic protein (GFAP) were employed in 
the study.  As an internal control, we used the house-keeping gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH).  The PCR master mix included 1 x SYBR® Green (Applied 
Biosystems, Foster City, CA), and forward and reverse primers (0.4μM each).  A 96-well optical 
plate was used to put the master mix and cDNA templates into it.  The plate was capped and 
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spun in order to settle all of the contents.  The 7500 Fast Real-Time PCR System (Applied 
Biosystems, Foster City, CA) was used to read the plate.  The following profile was used: 50◦C 
for 2 min, 95◦C for 10 min, and 40 cycles of 95◦C for 15s and 60◦C for 1 minute.  Threshold 
cycle (Ct) values for each sample and primer pair were obtained and analyzed with the delta-
delta (??) Ct method(Livak and Schmittgen, 2001; Schmittgen and Livak, 2008) in order to 
calculate the fold change (R) in each target gene.  The following equations were used: 
?Ct = Ctsample − CtGAPDH 
??Ct = ?Cttest surface – ?Ctcontrol surface 
R = 2−??Ct 
Table 3.  Primer sequences for real-time PCR used in biomaterials study. 
Cells Category Gene  Primer Sequence 
C6 rat 
astrocytoma 
cells 
Housekeeping gene GAPDH 5’-TGGCCTTCCGTGTTCCTACC-3’ (F) 
5’-AGCCCAGGATGCCCTTTAGTG-3’ (R) 
Proliferation gene MAP2K1 5’-TTCAAGGTCTCCCACAAGCCATCT-3’ (F) 
5’-TTGATCCAAGGACCCACCATCCAT-3’ (R) 
Activation gene GFAP 5’-GTTGTGTTCAAGCAGCCTGG-3’ (F) 
5’-CCAGTGAGTAAAGGTGACAG-3’ (R) 
 
5.2.6 Viability Test 
In order visually observe the morphology and viability of the cells on the different 
surfaces; we used the Live/Dead® viability/cytotoxicity assay (Invitrogen, Carlsbad, CA).  
Calcein AM (2μm in phenol red free DMEM) was used to stain the live cells a green fluorescent 
color that can be seen using an emission filter (FITC) of ~488.  Ethidium homodimer (EthD-1) 
(4μm in phenol red free DMEM) was used to stain the dead cells a red fluorescence, which can 
be seen using an emission filter at ~528.  The samples were incubated in the Live/Dead stain for 
20-30 minutes inside the incubator (37oC).    Thereafter, the samples were mounted onto slides 
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using Prolong Gold antifade mounting gel (Invitrogen, Carlsbad, CA) and viewed under a Zeiss 
Axio Observer Inverted Microscope (Carl Zeiss Inc).  Images for each sample were taken in the 
same location with both the red and green filters.   
5.2.7 Cell Morphology Analysis 
Fluorescence staining was utilized to image the cells’ cytoskeleton along with the 
nucleus.  The cells were washed in phosphate buffered saline (1X PBS) and fixed in 4% 
paraformaldehyde for 20 minutes.  The cells were washed in PBS, and then permeablized by 
incubation for 25 minutes in 1X PBS containing 0.25% Triton X-100.  The cells washed, blocked 
with 1% fetal bovine serum (FBS) for 25 minutes and washed again with 1X PBS.  Cells were 
stained with Rhodamine Phalloidin in 1X PBS (Invitrogen, Carlsbad, CA) for 20 minutes at 
room temperature in the dark.   Double staining of the nucleus was done with 2μg/mL of 4',6-
diamidino-2-phenylindole (DAPI; Sigma-Aldrich, St. Louis, MO) for 20 minutes at room 
temperature in the dark.  Thereafter, the samples were mounted onto slides using Prolong Gold 
antifade mounting gel (Invitrogen, Carlsbad, CA) and viewed under a Zeiss Axio Observer 
Inverted Microscope (Carl Zeiss Inc).  Images for each sample were taken in the same location 
with both the red and DAPI filters.   
5.2.8 Image Analysis 
Image J software was used to quantify the number of live cells versus the dead cells, 
calculate the aspect ratio and the projected area of the cells.  Each image was first converted to 
an 8-bit grayscale, following which a threshold binary image was created.  An average area of 
stained live and dead cells was measured and used to set a global scale of a particle size (average 
area of stained dead cell 50μm2 and stained live cell 80μm2).  Thereafter, the cells were counted 
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using the analyze particles function.  The following formula was used to calculate the percentage 
of live and dead cells:  
 
% of live cells =                 # of  live (or dead) cells_______   *100 
                  sum of total cells (live + dead) 
 
The aspect ratio of the nucleus was used to measure the spreading of cells.  It is calculated by 
taking the ratio of the major axis to the minor axis of each cell.  A perfect circle has an aspect 
ratio of 1 and a line has an aspect ratio of infinity.   The projected area of the cell’s nucleus was 
measured by taking the total area of the nucleus.  The circularity of the nucleus was measured by 
taking the ratio of the area of the nucleus over the area of a circle.  A perfect circle will have a 
circulatory of 100%.   
5.2.9 Statistical Analysis 
All of the data are presented as a mean ± standard error of the mean.  Experiments were 
performed in triplicates and repeated four independent times.  There were minimally 15 samples 
analyzed per group.  PASW software (version 18.0) was utilized for statistical analysis.  In order 
to evaluate statistical significance between the materials groups over time with the MTT assay, 
aspect ratio, projected area and circularity a one way analysis of variance (ANOVA) was 
utilized.  A nonparametric statistical analysis was used to test for statistically significant 
differences between the different material groups over time for the RTPCR studies and the 
Live/Dead analysis, because parametric  statistical methods could not be completed due to 
insufficient power from a small sample size, the exact tests, which were designed for small, 
sparse, heavily tied, or unbalanced data and the validity of the corresponding large sample theory 
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is in doubt, were conducted in order to be able to make reliable inferences by computing exact p 
values for a very wide class of hypothesis tests, including one-, two-, and K sample tests, tests 
for unordered and ordered categorical data, and tests for measures of association.   
5.3 Results 
5.3.1 Surface Chemistry Characterization 
Energy-dispersive X-ray spectroscopy (EDX) found that there was some antimony on the 
surface of the SU-8 substrate (Figure 13). However, X-ray photoelectron spectroscopy (XPS) 
was not able to detect antimony during both compositional survey scans at a pass energy of 100 
eV and  high-resolution detailed scan at a pass energy of 25 eV. This indicated that the presence 
of antimony was bellow the detection limit which is less than 1% of the total chemical 
composition of SU-8.   
        A 
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Figure 13. A) EDX of SU-8 shows low levels of antimony on the surface of the substrate.  B) XPS 
survey scan at pass energy of 100eV was not able to detect any antimony. 
 
5.3.2 MTT Proliferation Assay 
The proliferation assay results revealed significance between the number of cells on the 
different material surfaces at three days (Figure 14).    PMMA had significantly (p<0.005) less 
cells on its surface compared to SU-8, silicon and platinum surfaces on day one.  Moreover, it 
was found that SU-8 had a significantly (p<0.005) higher volume of initial cell attachment in 
comparison to silicon, platinum and PMMA on day one.  In fact, there were twice as many cells 
adhering onto SU-8 compared to the other materials.  There were significantly less (p<0.005) 
cells on PMMA compared to the control on day three.  Additionally, there were significantly less 
(p<0.005) cells on silicon compared to the other three material surfaces.  Day seven revealed 
significantly fewer (p<0.005) cells on PMMA compared to platinum.  Moreover, results showed 
the cells proliferated at significantly different rates on the different materials (Figure 15).  The 
growth rates of the astrocytes on SU-8, silicon and platinum were found to be significant 
between all measured intervals (p<0.05 on SU-8 between day one and day three and p<0.005 for 
B 
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all other time intervals).   Cells seeded on PMMA were found to have a steady growth rate, 
similar to the control.   
 
Figure 14. MTT Proliferation assay.  PMMA had significantly fewer cells attach by day one compared to 
the other test materials (SU8, silicon, and platinum) surfaces, while SU8 had significantly highest amount 
of  cells attach by day one.  *p <0.05 compared to control, ¤p <0.05 compared to PMMA, §p <0.05 
compared to SU8, +p <0.05 compared to silicon. 
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Figure 15. Growth rates of astrocytes on biomaterials.   The growth rates of astrocytes on SU8, silicon 
and platinum were found to be significant between all measured time intervals *p <0.05. 
 
5.3.3 Relative Gene Expression 
Astrocyte MAP2k1 relative gene expression was significantly lower (p<0.05) on all 
surfaces compared to the control surface at both days three and seven (Figure 16).  Moreover, 
compared to the other test surfaces, cells on SU-8 had significantly (p <0.05) less MAP2k1 gene 
expression on day three.  Similarly, there was a significantly lower amount of MAP2k1 gene 
expression from cells on PMMA compared to those on platinum and silicon on day three.  
MAP2k1 gene expression from cells on silicon on day seven were significantly less (p <0.05) 
compared to the control, platinum and PMMA.        
*
*
*
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Figure 16. RTPCR MAP2k1 relative gene expression.  The control is represented as the red line *p <0.05 
compared to control, ¤p <0.05 compared to PMMA, §p <0.05 compared to SU8, +p <0.05 compared to 
silicon. 
On day three, there was significantly less (p <0.05) GFAP relative gene expression found 
by cells growing on PMMA compared to those growing on the SU-8 and silicon surfaces (Figure 
17). By day seven, there was significantly less (p <0.05) GFAP relative gene expression from 
PMMA compared to silicon and platinum surfaces. Furthermore, on day seven, there was 
significantly less (p <0.005) GFAP relative gene expression found by cells growing on SU-8 
compared to those growing on the control, silicon and platinum surfaces. 
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Figure 17. RTPCR GFAP relative gene expression.  The control is represented as the red line.  *p <0.05 
compared to control, ¤p <0.05 compared to PMMA, §p <0.05 compared to SU8. 
 
5.3.4 Cell Morphology 
In order to assess the morphology of the cells quantitatively, the aspect ratio, projected 
area and the circularity of the cells’ nucleus were calculated (Figure 18).  Compared to the 
control, all of the test materials showed a significant difference (p <0.005) of the cells’ nucleus 
aspect ratio and projected area on all three time points.  The nucleus of cells on platinum had the 
largest projected area on day three compared to the other materials.  Moreover, the projected area 
of the nucleus on PMMA resembled most to that of cells on the control surface.  It was also 
found that the cells’ nucleus aspect ratio on PMMA and SU-8 were similar to that of cells on the 
control surface on all three time points measured.  The aspect ratio of the cells’ nucleus on 
platinum was the highest on day one.  In addition, silicon showed the highest cell nucleus aspect 
ratio on day three.  There was not any statistical significance found when comparing the 
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circularity of the astrocytes’ nucleus on the different materials.  Cells on platinum had the lowest 
circularity of their nucleus on days one and seven, whereas cells on PMMA had the highest 
circularity on days one and three.   
 
 
F 
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Figure 18. A-E) Rhodamine phlalloidin cytoskeleton stain double stained with DAPI for cell nucleus on 
day 3 (40X) of cells on SU-8, silicon, platinum, PMMA and control surfaces respectively. F) projected 
area of cells’ nucleus G) aspect ratio of cells’ nucleus H) circularity of the cells’ nucleus *p <0.005 
compared to the control. 
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5.3.5 Viability Assay 
Astrocytes on platinum had significantly higher (p <0.05) viability on platinum surface 
compared to the control, PMMA and silicon on day three post incubation (Figure 19).  Moreover, 
cells growing on PMMA had significantly less (p <0.05) viability compared to those on SU8 on 
day three.  However, by day seven, astrocytes on PMMA were significantly (p <0.05) more 
viable than on silicon.  Overall, there were fewer than 10% dead cells on any material surface by 
seven days.  
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Figure 19. Live/Dead images taken on day 3 (20X) a) SU-8 b) silicon c) platinum d) PMMA e) control 
polystyrene f) viability results of cells on materials surface on days 3 and 7 days in vitro. *p <0.05 
compared to control, ¤p <0.05 ompared to PMMA, +p <0.05 compared to silicon. 
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5.4 Discussion 
In summary, this study showed astrocyte behavior on PMMA to be very similar to that on 
the control surface.  Cells growing on platinum and silicon were the most reactive compared to 
other surfaces.  Moreover, SU-8 did not show any evidence of cytotoxicity.  As previously 
mentioned, some of the characteristics of reactive astrocytes include, hypertrophy, hyperplasia, 
upregulation of GFAP, and irregularly shaped nuclei.  This study utilized these predefined 
characteristics of a reactive astrocyte through a combination of techniques.  As a result of this 
study, we have classified guidelines to create a biocompatible neural electrode.  Cytotoxicity 
testing is a good preliminary step in evaluating the biocompatibility of a medical device (Kotzar 
et al., 2002).  Therefore, an increase in cell death on a biomaterial characterizes that biomaterial 
as incompatible.  Since hyperplasia indicates astrocyte reactivity, a linear proliferation rate 
identifies unreactive astrocytes(Polikov et al., 2006; Polikov et al., 2005; Turner et al., 1999).  It 
has been well established that an increase in GFAP expression is a result of an activated 
astrocyte (Bhandari et al., 2010; Negi et al., 2010a; Polikov et al., 2005).  The cells’ nuclei have 
to maintain a round shape with an area no more than 100 μm2.  Normal, inactivated astrocytes 
have round cell bodies with a diameter of 10-20μm, therefore large, irregularly shaped nuclei 
indicate an activated astrocyte (Bruce Alberts, 2008; Eric J. Nestler, 2001; Kühnel, 2003).   
Defiance of any of these guidelines may indicate an inflammatory response which results in 
classifying a biomaterial as incompatible.     
Previous studies have found cytotoxic effects from SU-8(De Boeck et al., 2003; Vernekar 
et al., 2009), silicon(Kotzar et al., 2002; Szarowski et al., 2003) and platinum(Griffith and 
Humphrey, 2006) cultured with neuronal cells or implanted in vivo.  In a study done by Griffith 
et al with Rhesus macaque, glial scarring was found around platinum wires implanted into the 
60 
 
 
motor cortex for periods up to three months and three years(Griffith and Humphrey, 2006).  
Results of our current study are evident of the astrocyte reactivity to platinum on an in vitro 
level.  Astrocytes cultured on platinum had the highest levels of GFAP gene expression and the 
largest nuclei projected area on day three.  Furthermore, the astrocyte’s nuclei on platinum had 
the lowest circularity at all time points.  The combination of these findings implies astrocyte 
reactivity on platinum (Bhandari et al., 2010; Polikov et al., 2005).  Although silicon is 
commonly used in neural electrodes, our results indicate astrocyte reactivity to silicon, possibly 
explaining the limitations of current electrode design (Kotov et al., 2009; Zhong and 
Bellamkonda, 2008).  Results of astrocytes on silicon are similar to those on platinum.  Silicon 
had the second highest number of cells by day seven and second highest rate of proliferation, 
with platinum being the highest.  Astrocytes on silicon had the lowest MAP2k1 expression by 
day seven, indication that the hyperplasia caused confluency on the surface.  The lower cell 
viability on the silicon surface, compared to the other materials on day seven, is another 
indication of the cells reaching confluency in the silicon surface by say seven.  Cells on silicon 
had the second highest GFAP expression, again with platinum being the highest on both days.  It 
was interesting to note that the astrocytes on silicon had the smallest projected area on day one.  
This may indicate a lack of initial cell spreading on the materials. Moreover, the astrocytes' 
projected area and aspect ratio increased significantly from day one to day three, indication of 
hypertrophy, a sign of reactive astrocytes.      PMMA and polysytrene are both considered 
biocompatible materials commonly used as substrates for mammalian cell culture (Ni et al., 
2009).  PMMA has been used for medical applications for a number of years due to its excellent 
tissue compatibility(Frazer et al., 2005).  Our results found the cellular characteristics, reactions 
and growth rates of astrocytes grown on PMMA resembled closely to that of cells grown on the 
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control surface.  Additionally, the astrocyte GFAP gene expressions of cells grown on PMMA 
were lower than the control, signifying a lack of astrocyte reactivity.    
Material properties of SU-8 suggest that it could be used for a compatible neuron-based 
device(Wu et al., 2006).  However, there have been several studies revealing cytotoxicity with 
SU-8, thus rendering it a controversial material for biomedical purposes (Vernekar et al., 2009; 
Wu et al., 2006).  Kotzar et al performed an investigative study evaluating the biocompatibility 
of numerous bioMEMS materials, including silicon and SU-8.  They found that these materials 
were not cytotoxic with mouse fibroblasts in vitro.  Furthermore, another study they performed 
using rabbit muscle implantation lead them to classify these materials as non-irritants.  However, 
when conducting aqueous physiochemical tests, they found that SU-8 leached detectable 
nonvolatile residues(Kotzar et al., 2002; Ni et al., 2009).   Vernekar et al examined primary 
neuronal cell cultures from rats on various surface treatments of SU-8 for 21 days in vitro.  They 
concluded that the current formulas of SU-8/SU-8 2000 are cytotoxic to primary neurons, thus 
rendering them incompatible.  Vernekar found that he neurons had poor adhesion to the SU-8 
surfaces and less that 10% of neurons survived when cultured adjacent to or on the SU-8 
substrates.  Moreover, they found toxins such as fluorine and antimony leaching from the SU-8 
2000.  These chemicals are typically found in the photo acid generator in the SU-8 2000 formula.  
It was noted that the neurons adjacent to the samples were dead(Vernekar et al., 2009).  On the 
other hand, studies performed by Kisaalita's group concluded that SU-8 mictrostructures are 
viable platforms for cell culturing systems for cell-based biosensing against drugs and promoting 
human neuroblastoma cells' resting membrane potential(Wang et al., 2009; Wu et al., 2006).   
Although studies have found cytotoxic elements in SU-8, our study shows otherwise.  
The XPS and EDX results indicate little to no cytotoxic chemical, antimony, in our SU-8 
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formula.  There are few studies that raised concern about antimony leaching as possible cause of 
cytotoxicity (Cogan et al., 2009; Vernekar et al., 2009).   However, the minimum acceptable amount of 
antimony for biomedical application of SU8 has not yet been determined.  We found there was at least 
93% viability of cells on SU-8 for up to one week in vitro, the initial adhesion of cells was 
strongest on SU-8, the proliferation rates were steady and consistent with the control, the 
morphology of the nucleus was consistent with the control, and GFAP was lowest on SU-8 day 
seven.  The MTT assay revealed that the initial attachment of astrocytes to SU-8 was the highest.  
We found twice as many cells on SU-8 compared to the other material surfaces.  Our 
observations suggest SU-8 to be biocompatible.   
Studies have shown that PMMA reduces the adsorption of proteins by five to ten fold 
compared to polystyrene (Alaerts et al., 2001; Cogan et al., 2006).   By using a polymer that 
minimizes the adsorption of proteins, they found that the chemical influence of the polymer on 
the cells was reduced(Alaerts et al., 2001).  Proteins adsorb immediately after an implanted 
material comes into contact with physiological solutions.  This protein adsorption facilitates the 
cellular interaction with the substrate surface.  The number and strength of cells adhered to a 
substrate is inherently affected by the level of protein adsorption (Dupont-Gillain et al., 2004; Ni 
et al., 2009; Salakhutdinov et al., 2008).  Our results found the fewest number of astrocytes on 
PMMA compared to any other surface, which could be explained by a low amount of protein 
adsorption on PMMA.  Furthermore, there was 13% cell death on day three on PMMA surface 
most likely due to poor adhesion of cells on PMMA.  It can be hypothesized that cells died on 
PMMA due to lack of adherence.   
Surface hydrophobicity does have an effect on protein conformation, thus possibly 
making the protein's cell binding domain unavailable for cells to attach(Ni et al., 2009).  SU-8 
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and PMMA are both hydrophobic materials, while silicon and platinum are hydrophilic(Burton 
and Bhushan, 2005; Shirtcliffe et al., 2004; Zisman, 1965; Zorba et al., 2006).  Burton et al found 
that hydrophobicity is inversely correlated to adhesive strength; an increase in hydrophobic 
characteristics therefore reduces adhesive force(Burton and Bhushan, 2005).  It is hypothesized 
that the cellular adhesive force on the SU-8 and PMMA was not strong.  This is verified by the 
lack of cell spreading, indicated by the lowest aspect ratio and projected area from these two 
materials compared to silicon and platinum.  Moreover, the results from the RTPCR MAP2k1 
gene expression imply that the astrocytes on the SU-8 and PMMA substrates have room to 
continue proliferation after day seven, most likely due to the initial low adhesive force of the 
cells on these surfaces, thereby having cell detachment and emptying space for future cell growth 
and spreading.  On day seven, cells on the PMMA and SU-8 surfaces showed an increase in 
MAP2k1 gene expression.  Similarly, in a pilot study we conducted (data not shown), these two 
surfaces showed the highest increase in cell proliferation at day ten.  These results indicate that 
cells grown on SU-8 and PMMA surfaces proliferate at a slower rate than cells growing on 
silicon and platinum.  Cells grown on silicon and platinum substrates had a decreased MAP2k1 
gene expression which further verifies full confluency by day seven in vitro.    
A major hypothesis in current research implies that reactive astrocyte formation of the 
astroglial scar results in the chronic impediment of the electrodes and 
neurodegeneration(Frampton et al., 2010; McConnell et al., 2009).  In order for this hypothesis 
to be validated, astrocytes need to increase reactivity with time, or at the very least maintain the 
same level of reactivity over the course of time.  The results of this study found that the 
expression of GFAP decreased in astrocytes growing on all of the different material surfaces 
over time.  In addition, the projected area of the cells’ nuclei had decreased over time, 
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demonstrating that the area of the nucleus is directly proportional to the state of reactivity of the 
astrocyte.  These results indicate that the astrocyte reaction to the materials was not a chronic, 
but rather an acute response.   
5.5 Conclusions 
The current study utilized a combination of techniques for characterizing the 
biocompatibility of cells in vitro on neural electrode materials.  This information should be 
helpful in establishing sound guidelines of which neural implant materials should meet in order 
to be depicted biocompatible.  This study has shown evidence of non-cytotoxicity of SU-8.  We 
have confirmed the biocompatibility of PMMA with astrocytes. This data suggests the need of 
future investigations of both materials under in vivo conditions.  We have shown astrocytes 
depict reactive characteristics when grown on platinum and silicon surfaces, thus rendering the 
need to find more biocompatible, conducting materials for neural electrode fabrication.   
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CHAPTER 6 
 6.1 Evaluation of Protein and Cellular Response to Nanopatterning  
 
Numerous scientific techniques have been used for improving the cellular response to 
implanted neural electrodes.  Studies have been performed on alterations in the device size, 
shape, material choice, and surface topography.  Moreover, literature has shown (see Chapter 4 
for more details) the effects surface topography modifications has on cellular behavior, more 
importantly, the effects nano-sized alterations have on protein adherence and cellular behavior.  
Depending on pattern size, proteins have been shown to adsorb at different rates, quantities, and 
even change their conformation due to the pattern.  Studies have revealed cells alter their 
morphology, adhesion, migration, alignment, gene expression, and viability depending on the 
surface topography.  This evidence lends support for our proposed work which examines the 
effect specific nanopatterning features will have on protein adsorption and astrocyte response.  
Preliminary data collected in this lab was utilized in determining the material and nanopattern 
feature dimensions used in this study (Ereifej et al., 2011; Salakhutdinov et al., 2008).  
Nanopatterned surfaces were fabricated with nano-imprint lithography on PMMA surfaces.  The 
rate of protein adsorption, quantity of protein adsorption, cell alignment, morphology, adhesion, 
proliferation, viability and gene expression were compared between nanopatterned surfaces of 
different dimensions.     
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6.2 Methodology  
6.2.1 Nanopattern Fabrication 
Nanoimprint lithography (NIL), otherwise known as hot embossing, was utilized to 
create various nanopatterned surface.  Specifically, the JenOptik HEX03 hot embossing system 
(Figure 20) (SSIM laboratory at Wayne State University) was used.  Goodfellow UV-grade 
poly(methyl methacrylate) (PMMA) was the substrate.  The processing temperature was 105-
195°C and the applied controllable force is 300N – 3kN (Figure 21).  Reflective holographic 
grated molds were purchased from Edmund Optics (Barrington, NJ) and used to make the 
patterned substrate with a period of 3600 grooves/mm, 1800 grooves/mm.  A flat mirror mold 
was used for a controlled non-patterned surface. The embossed substrates were cut into 1cm2 
wafers.  As a standard surface, we used polystyrene cover slips.  All samples were cleaned with 
isopropanol, followed by 1×PBS and distilled water washes, and then sterilized under UV light 
for two hours.   
 
Figure 20. A) Nanoimprint lithography machine.  B) Area in NIL machine in which the mask is placed. 
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Figure 21.  Schematic representation of material fabrication.  Shown here is an example using the 
nanopatterned substrate; the same steps were used to make the non-patterned samples. 
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6.2.2 Atomic Force Microscopy 
The dimensions of the nanopatterned PMMA substrates were characterized by Dimension 
3100 AFM (VEECO) in the tapping mode in ambient air. The height, amplitude, and phase 
images were obtained using silicon tapping tips (nanoScience Instruments, VistruaProbes T300) 
with resonance frequency of 300 kHz and tip radius less than 10 nm. The scan rate was 1–3 
Hz. Height images are plane-fit in the fast scan direction with no additional filtering operation. 
The dimensions of the nanopattern structure were determined using the sectional height analysis 
command (Nanoscope 5.30r3sr3) by manually measuring the lateral diameters and vertical 
heights of 3 - 5 different spots on each sample. 
6.2.3 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) was utilized to image cells and brain tissue on the 
substrate surface.  In particular, the Environmental SEM Quanta FEG 450 (FEI Company, 
Hillsboro, OR) was used at an operating high voltage of 10kV and pressure of 5.5 Torr.  On day 
seven, samples were fixed in a 4% paraformaldehyde solution for 30 minutes at room 
temperature (RT).  Following three rinses in 1×PBS, the samples were then washed in distilled 
water in order to remove salt crystals from the PBS.   
6.2.4 Ellipsometry 
In order to measure the rate of protein adsorption, the Beaglehole intruments NZ - 
Picometer Ellipsometer was used.  This is a phase modulated ellipsometer that uses a HeNe laser 
at 633nm wavelength.  The brewester’s angle for PMMA was set at 56o.  After which, the 
samples were placed into a quartz cuvette and 1µg/ml of protein (fibronectin or collagen) was 
pipetted into the cuvette.  The machine was set to run for three hours and collected data every ten 
seconds.  The refractive index of the protein is required to measure thickness; however, thickness 
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was not measured in this study.  Ellipticity depends on the refractive index of the ambiance of 
substrate, which in our case is the protein; it is proportional to thickness. Same ellipticity may 
correspond to different thickness depending on the ambiance of the substrate.  This study 
conveyed the change along the y-axis over time in order to determine the arbitrary rate of protein 
adsorption on the nanopatterned and non-patterned substrates.   
6.2.5 Protein Assay 
The amount of protein adsorption was measured through the Micro BCA Protein Assay 
(Thermo Scientific, Waltham, MA).  Wafers were incubated for two hours at room temperature 
with a 200µl droplet of either 10µg/ml of fibronectin or collagen.  Thereafter, 150µl of the 
protein was collected and pipetted into a 96-well plate.  As per manufacturer’s protocol, 150µl of 
the working reaction was mixed with the protein in the 96-well plate on a shaker for 30 seconds.  
The standard curve was used to determine the protein concentrations.  The standard curve was 
created by using serial dilutions of bovine serum albumin (BSA).   The plate was covered and 
incubated at 37oC for two hours, cooled to room temperature and then read at 562 nm on a 
microtiter plate reader.   
6.2.6 Contact Angle Measurement 
The water contact angle was determined from the shape of axisymmetric menisci of 5µl 
distilled water drops using a goniometer.   
6.2.7 Cell Cultures 
This study utilized C6 rat astrocytoma cell line (ATCC, Manassas, VA).  The cells were 
maintained in a F-12K medium supplemented with 10% horse serum, 2.5% fetal bovine serum 
(FBS), and 1% antibiotics-antimycotic. The cells were kept in a humidified incubator with the 
following setting conditions: 90% humidity, 5% CO2 and 37.8oC. The media was changed twice 
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a week.  Cells were detached using trypsin and then centrifuged at 1000rpm.  The cells were then 
resuspended in culture media, stained with Trypan blue and counted using a hemocytometer.  
There were 5000 cells in 100μl droplet of culture media loaded onto each sample in a 24 well 
plate.  Following three hours of incubation at 37oC, 500μl of culture media was added to each 
well.   
6.2.8 Proliferation Assay 
The methylthiazolyldiphenyl tetrazolium bromide (MTT) colorimetric assay was 
employed to determine the number of cells and the rate at which they proliferated at days 1, 3, 
and 7 post seeding.  At each time point, 0.5 mg/mL MTT reagent was added to the culture 
medium and reincubated for 5 hours in the dark at 37oC until the yellow MTT was reduced to 
purple formazan crystals.  The culture media was removed carefully, so as to not disturb the 
formazan crystals, and replaced by dimethyl sulfoxide (DMSO), which solubilized the formazan 
crystals and cells. Absorbances were read at 570nm and 650 nm in a microtiter plate reader.  The 
optical densities were calculated by subtracting the 650nm reference wavelength from the 570nm 
absorbance reading.  To measure the approximate number of cells on the given test days, a 
growth curve for C6 cells was also generated by performing a MTT assay on a graded series 
(range from 2,000 to 1,500,000 cells) of cells plated on polystyrene culture dishes. 
6.2.9 Real Time PCR 
Real time PCR was used to measure gene expression from the different samples relative 
to the control surface (polystyrene samples).  The total RNA from the samples was extracted on 
days 3 and 7 post seeding with Trizol (Invitrogen, Carlsbad, CA) following the manufacturer’s 
protocol.  The RNA concentration and purity was determined using a spectrophotometer through 
UV absorbance at 260nm and 280nm.  Reverse transcriptase using the oligo(dT)20 primer 
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converted the mRNA to a cDNA template using a thermal cycler (Mastercycler Gradient, 
Eppendorf, Hauppauge, NY).  For PCR analysis, we used cDNA equivalent to 40ng of total 
RNA.  Specific primer pairs (Table 4) for proliferation, mitogen-activated protein kinase kinase 
1 (MAP2K1), and astrocyte activation, glial fibrillary acidic protein (GFAP) were employed.  As 
an internal control, we used the house-keeping gene glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH).  The PCR master mix included 1 x SYBR® Green (Applied Biosystems, Foster City, 
CA), and forward and reverse primers (0.4μM each).  cDNA templates and master mix were read 
in a 96-well optical plate using a 7500 Fast Real-Time PCR System (Applied Biosystems, Foster 
City, CA).  The following profile was used: 50◦C for 2 min, 95◦C for 10 min, and 40 cycles of 
95◦C for 15s and 60◦C for 1 minute.  Threshold cycle (Ct) values for each sample and primer pair 
were obtained and analyzed with the delta-delta (∆∆) Ct method(Livak and Schmittgen, 2001; 
Schmittgen and Livak, 2008) in order to calculate the fold change (R) in each target gene.  The 
following equations were used: 
∆Ct = Ctsample − CtGAPDH 
∆∆Ct = ?Cttest surface – ∆Ctcontrol surface 
R = 2−∆∆Ct 
 
Table 4. Primer sequences for real-time PCR used in nanopatterned PMMA studies. 
Cells Category Gene  Primer Sequence 
C6 rat 
astrocytoma 
cells 
Housekeeping gene GAPDH 5’-TGGCCTTCCGTGTTCCTACC-3’ (F) 
5’-AGCCCAGGATGCCCTTTAGTG-3’ (R) 
Proliferation gene MAP2K1 5’-TTCAAGGTCTCCCACAAGCCATCT-3’ (F) 
5’-TTGATCCAAGGACCCACCATCCAT-3’ (R) 
Activation gene GFAP 5’-GTTGTGTTCAAGCAGCCTGG-3’ (F) 
5’-CCAGTGAGTAAAGGTGACAG-3’ (R) 
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6.2.10 Viability Test  
In order visually observe the morphology and viability of the cells on the different 
surfaces; the Live/Dead® viability/cytotoxicity assay (Invitrogen, Carlsbad, CA) were used.  
Calcein AM (2µm in phenol red free DMEM) was used to stain the live cells a green fluorescent 
color that can be seen using an emission filter (FITC) of ~488.  Ethidium homodimer (EthD-1) 
(4µm in phenol red free DMEM) was used to stain the dead cells a red fluorescence, which can 
be seen using an emission filter at ~528.  The samples were incubated in the Live/Dead stain for 
20-30 minutes inside the incubator (37oC).    Thereafter, the samples were mounted onto slides 
using Prolong Gold antifade mounting gel (Invitrogen, Carlsbad, CA) and viewed under a Zeiss 
Axio Observer Inverted Microscope (Carl Zeiss Inc).  Images for each sample were taken in the 
same location with both the red and green filters.   
6.2.11 Cell Nuclei and Cytoskeleton Staining/ Cell Adhesion  
Fluorescence staining was utilized to image the cells’ cytoskeleton along with the 
nucleus.  The cells were washed in phosphate buffered saline (1×PBS) and fixed in 4% 
paraformaldehyde for 20 minutes.  The cells were washed in PBS, and then permeablized by 
incubation for 25 minutes in 1X PBS containing 0.25% Triton X-100.  The cells washed, blocked 
with 1% fetal bovine serum (FBS) for 25 minutes and washed again with 1X PBS.  Cells were 
stained with Rhodamine Phalloidin in 1×PBS (Invitrogen, Carlsbad, CA) for 20 minutes at room 
temperature in the dark.   Double staining of the nucleus was done with 2µg/mL of 4',6-
diamidino-2-phenylindole (DAPI; Sigma-Aldrich, St. Louis, MO) for 20 minutes at room 
temperature in the dark.  Thereafter, the samples were mounted onto slides using Prolong Gold 
antifade mounting gel (Invitrogen, Carlsbad, CA) and viewed under a Zeiss Axio Observer 
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Inverted Microscope (Carl Zeiss Inc).  Images for each sample were taken in the same location 
with both the red and DAPI filters.   
6.2.12 Image Analysis 
Image J software was used to quantify the number of live cells versus the dead cells, and 
calculate the number of adhered cells.  Each image was first converted to an 8-bit grayscale from 
which a threshold binary image was created.  An average area of stained live and dead cells was 
measured and used to set a global scale of a particle size.  The average area of stained dead cell 
was 50µm2 and a stained live cell was 80µm2.  Thereafter, the cells were counted using the 
analyze particles function.  The following formula was used to calculate the percentage of live 
and dead cells:  
% of live cells =                 # of  live cells_______   *100 
sum of total cells (live + dead) 
 
In order to calculate the number of adhered cells, total DAPI stained area in an image (each 
image was 217µm × 162µm) was measured, then divided by the average measured cell nucleus 
size (50μm2).   
6.2.13 Statistical Analysis 
All of the data are presented as a mean ± standard error of the mean.  Experiments were 
performed in triplicates and repeated three independent times.  PASW software (version 18.0) 
was utilized for statistical analysis.  A nonparametric statistical analysis was used to test for 
statistically significant differences between the different material groups over all time points for 
the RTPCR, MTT assay, BCA assay, viability and cell adhesion studies.  Parametric statistical 
methods could not be completed due to insufficient power from a small sample size, mean values 
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were either not normally distributed or the variances of the data were not heterogeneous.  The 
exact tests were conducted in order to be able to make reliable inferences by computing exact p 
values for a very wide class of hypothesis tests, including one-, two-, and K sample tests, tests 
for unordered and ordered categorical data, and tests for measures of association.   
6.3 Results 
6.3.1 Nanopattern Fabrication 
Figure 22 depicts the successful fabrication of patterns with periods of either 3600 
grooves/mm or 1800 grooves/mm, which translates to a 277nm width versus a 555nm width 
respectively, and both patterns had a depth of 200nm.   
 
     
     
 
Figure 22.  Images of the two nanopattern substrates and flat PMMA substrate (prior to hot embossing).   
A) Scanning Electron Microscopy  B) Atomic Force Microscopy 
A 
B 
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6.3.2 Protein Assay 
Results from the protein assay demonstrated at least 9µg/ml of collagen was adsorbed 
onto all surfaces, while 7µg/ml of fibronectin adsorbed onto the surfaces (Figure 23).  There was 
significantly more (p<0.01) collagen adsorption on all surfaces compared to fibronectin 
adsorption.  Moreover, there was significantly less (p<0.05) fibronectin adsorption on the 3600 
patterned surface compared to the 1800 patterned, non-patterned, and PMMA surfaces.  There 
was significantly elevated levels (p<0.05) of collagen adsorption on the PMMA surface 
compared to the 1800 patterned surface.   
 
Figure 23. Micro BCA protein adsorption assay results.  *p<0.05 fibronectin data compared to 3600, 
¤p<0.05 fibronectin data compared to PMMA, §p<0.05 collagen data compared to PMMA, +p<0.01 
fibronectin data on all surfaces compared to collagen data on all surfaces. 
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6.3.3 Ellipsometry 
Ellipsometry results (Figure 24) indicated that the rate of collagen adsorption was 10-fold 
faster as compared to the fibronectin adsorption.  Results demonstrated that both of the 
nanopatterned substrates had faster rates of collagen and fibronectin adsorption compared to the 
non-pattern surfaces.  Additionally, the 3600 pattern substrates had the highest rate of both 
fibronectin and collagen adsorption compared to 1800 pattern and non-pattern substrates.   
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Figure 24. Ellipsometry results depicting the rate of (A) collagen (B) fibronectin adsorption on the two 
different sized patterns and non-patterned surface. 
B 
A 
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6.3.4 Contact Angle 
Contact angle measurements revealed that the adsorption of fibronectin and collagen on 
the material substrates made the surfaces more hydrophilic (Table 5).    
Table 5.  Contact angle measurements, shown and mean ± standard error. 
  
No 
Protein  Collagen Fibronectin
3600 76 ± 2 66 ± 1 65 ± 3 
1800 62 ± 1 63 ± 1 62 ± 3 
NON 74 ± 2 65 ± 1 76 ± 2 
PMMA 66 ± 3 57 ± 2 56 ± 1 
Control 68 ± 1 58 ± 2 57 ± 1 
 
 
6.3.5 Cell Alignment 
Phase contrast images taken at days one, three and seven, showed that over time the cells 
began to orient themselves in one direction (Figure 25).  Cells appeared to have a unique 
temporal response dependent on the pattern surface.  Cells grown on the 1800 pattern began to 
align in one direction after only one day in culture.  In contrast, cells cultured on the 3600 pattern 
did not fully orient in one direction until three days in culture.    As can be seen from the Figure 
25, cells grown on the non-patterned surface were randomly oriented along the surface at all time 
points.   
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Figure 25. Phase contrast images of astrocytes aligned on patterned and nonpatterned PMMA surfaces 
(20X). 
 
6.3.6 SEM 
SEM images (Figure 26) reveal that by day three, cells on both of the patterned surfaces 
grew along the nanopattern.  Moreover, the cells growing on the nanopattern surfaces had an 
elongated shape compared to the typical astrocyte star-like shape seen on the non-pattern 
substrate.  Cells followed the pattern whether in low densities or in complete confluence.   
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Figure 26.  SEM images of astrocytes growing on the hot embossed PMMA substrates on day three in 
culture (from left to right), 3600 nanopattern, 1800 nanopattern, and non-pattern. 
 
6.3.7 Viability Assay 
Results of the viability assay revealed that all of the substrates tested had at least 89% 
viability at both time points.   Cells cultured on the 1800 nanopattern substrates had significantly 
higher (p<0.05) viability on day three compared to cells cultured on 3600 nanopattern, PMMA 
and control substrates (Figure 27).  Cells grown on the 3600 nanopattern substrates had 
significantly lower (p<0.05) viability on day three compared to cells grown on non-nanopattern 
and control substrates.  Cells grown on the control and non-nanopattern substrates had 
significantly higher (p<0.05) viability on day three compared to those grown on PMMA.  
However, by day seven, cells cultured on PMMA had significantly higher (p<0.05) viability 
compared to 1800 nanopattern, 3600 nanopattern, and control substrates.  Cells grown on the 
non-nanopattern substrates had significantly higher (p<0.05) viability compared to the 3600 
nanopattern on day seven.   
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Figure 27.  Live/Dead images taken on day seven  a) 3600 nanopatterned b) 1800 nanopatterned c) non-
nanopatterned d) PMMA e) control polystyrene f) viability results of cells on materials surface on days 3 
and 7 days in vitro *p<0.05 data on day three compared to 1800, +p<0.05 data on day three 
compared to 3600, ¤p<0.05 data on day three compared to PMMA §p<0.05 data on day seven 
compared to PMMA, ∆p<0.05 data on day seven compared to 3600 
 
6.3.8 MTT Proliferation Assay 
Results of the MTT proliferation assay demonstrated a significant increase (p<0.05) in 
cell proliferation between day one and day three with 1800 nanopattern, 3600 nanopattern, and 
non-nanopattern substrates (Figure 28).  There was a significant increase (p<0.05) in proliferation 
between day three and seven with 1800 nanopattern, 3600 nanopattern, non-nanopattern and 
control substrates (Figure 28).  At day one, all nanopatterned substrates had significantly fewer 
F 
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(p<0.05) cells compared to the control, yet significantly more (p<0.05) cells compared to PMMA 
(Figure 28).  Results on day three showed similar findings, all substrates had significantly fewer 
(p<0.05) cells compared to the control and significantly more cells compared to PMMA (Figure 
29).   The 3600 nanopattern and non-nanopattern substrates had significantly fewer (p<0.05) 
cells on day three compared to the 1800 pattern substrate (Figure 29).  Day seven results showed 
all test substrates had significantly higher (p<0.05) number of cells compared to PMMA (Figure 
30).  However, compared to the control, only 1800 pattern, non-pattern, and PMMA had 
significantly more cells on day seven (Figure 30).  Moreover, compared to the 3600 pattern, the 
1800 pattern and non-pattern had significantly fewer (p<0.05) cells on day seven (Figure 30).  
Non-nanopattern substrates had significantly fewer (p<0.05) cells compared to 1800 pattern 
(Figure 30).    
 
Figure 28.   MTT proliferation assay.  *p<0.05 day one data compared to day three data, +p<0.05 day 
three data compared to day seven data 
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Figure 29.   MTT proliferation assay.  *p<0.05 data compared to control +p<0.05, data compared to 
PMMA 
 
Figure 30.   MTT proliferation assay.  *p<0.05 data compared to control +p<0.05, data compared to 
PMMA, ¤p<0.05 data compared to 1800 pattern 
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Figure 31.   MTT proliferation assay.  *p<0.05 data compared to control +p<0.05, data compared to 
PMMA, ¤p<0.05 data compared to 3600 pattern, §p<0.05 data compared to 1800 pattern 
 
6.3.9 Relative Gene Expression  
Results of GFAP relative gene expression on 3600 nanppattern were significantly lower 
(p<0.05) on day seven compared to 3600 nanopattern on day three and control on day seven.  It 
is important to note, that GFAP relative gene expression on 3600 nanopattern was lower on day 
seven compared to all substrates (Figure 32).  Moreover, GFAP relative gene expression was 
higher on the non-nanopattern substrates compared to all other substrates on both days.  
MAP2k1 relative gene expression of 3600 pattern on day seven was significantly lower (p<0.05) 
compared to control.  Result of MAP2k1 relative gene expression show PMMA had higher 
levels compared to all other substrates on day three (Figure 33). 
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Figure 32.  RTPCR GFAP relative gene expression.  The control is represented as the red line.  *p<0.05 
data compared to 3600 on day seven, ¤p<0.05 data compared to control at day seven 
  
Figure 33.  RTPCR MAP2k1 relative gene expression.  The control is represented as the red line.  
¤p<0.05 data compared to control at day seven 
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6.3.10 Cell Nuclei and Cytoskeleton Staining/ Cell Adhesion   
Cell nuclei stained with DAPI were used to measure the number of adhered cells after one day in 
culture in order to quantify cell adhesion characteritics.  Cells grown directly on the substrates, without 
any protein coating had significantly fewer (p<0.05) cells adhered across all substrate types compared to 
cells cultured on collagen or fibronectin coated substrates (Figure 34).  There were significantly more 
(p<0.05) cells adhered on PMMA coated with fibronectin compared to PMMA coated with collagen 
(Figure 34).  To the contrary, there were significantly fewer (p<0.05) cells adhered on 1800 patterned 
substrate coated with fibronectin compared to 1800 patterned substrate coated with collagen (Figure 34).   
Compared to uncoated 1800 patterned substrate, there were significantly fewer (p<0.05) cells 
adhered on the 3600 patterned, PMMA and control substrates not coated with protein (Figure 35).  
Similarly, compared to the non-patterned uncoated substrate, there were significantly fewer (p<0.05) cells 
adhered on the uncoated 3600 patterned, uncoated 1800 patterned, PMMA and control substrates (Figure 
35).  There were significantly fewer (p<0.05) cells adhered on the uncoated 3600 patterned and uncoated 
control surface compared to PMMA (Figure 35).   
There were significantly fewer (p<0.05) cells adhered on collagen coated 3600 pattern, 1800 
pattern, non-pattern, and PMMA compared to the control (Figure 36).  Compared to the collagen coated 
non-pattern substrates, there were significantly fewer (p<0.05) cells adhered on the 3600 pattern and 
PMMA substrates (Figure 36).   
Compared to both fibronectin coated 3600 pattern and 1800 pattern, there were significantly more 
(p<0.05) cells adhered on the fibronectin coated non-pattern, PMMA, and control substrates (Figure 37).   
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Figure 34.  Number of cells adhered on substrates coated with either 10µg/ml fibronectin  or 10µg/ml 
collagen or no protein at day one in culture.  *p<0.05 data compared to no protein, +p<0.05 data 
compared to collagen 
 
Figure 35.  Number of cells adhered on substrates not coated with proteins at day one in culture.  *p<0.05 
data compared to 1800, +p<0.05 compared to NON, ¤p<0.05 compared to PMMA 
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Figure 36.  Number of cells adhered on substrates coated with 10µg/ml collagen at day one in culture.  
*p<0.05 data compared to control, +p<0.05 data compared to NON 
 
Figure 37.  Number of cells adhered on substrates coated with 10µg/ml fibronectin at day one in culture.  
*p<0.05 data compared to 3600, +p<0.05 data compared to 1800 
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Results from the cell nuclei and cytoskeleton staining visually showed fewer numbers of cells on 
the substrates uncoated compared to the fibronectin and collagen-coated substrates (Figure 38).  
Moreover, these images revealed the cell morphology on the patterned substrates to be elongated 
compared to the star like morphology of the cells on the non-patterned, PMMA, and control substrates 
(Figure 38).   Cells on the 1800 patterned substrate had elongated morphology on both of the protein 
coated surfaces and the uncoated surfaces.  However, cells on the 3600 pattern substrate had a more 
defiant elongated morphology on both of the protein coated surfaces, and more of a star like morphology 
on the surface not coated with any proteins (Figure 38).    
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Figure 38.  Rhodamine phlalloidin cytoskeleton stain double stained with DAPI for cell nucleus on day 
one (40X) of cells on 3600 patterned, 1800 patterned, non-patterned, PMMA, and control surfaces coated 
with either 10µg/ml collagen, 10µg/ml fibronectin or no protein 
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6.4 Discussion 
Studies have shown that in a healthy adult brain, commonly found ECM proteins, such as 
fibronectin and collagen are scarce beneath the blood brain barrier and choroid plexus (Tate et 
al., 2007; Zimmermann and Dours-Zimmermann, 2008).  When brain tissue damage occurs, (ie 
during neural electrode implantation), the levels of fibronectin is found to be increased, most 
likely entering through the injured blood brain barrier  (Tate et al., 2007).  The binding of 
fibronectin to the glial cell receptor (RGD peptide)  has been shown to elevate their adhesion, 
migration, proliferation and production of cytokines (Hermanns et al., 2006; Mayeed et al., 2009; 
Tate et al., 2007; Thanawala et al., 2007).  This increase in glial cell number is paralleled with an 
increase in their reactivity, therefore resulting in glial scar formation (Hermanns et al., 2006; 
Mian et al., 2007; Tate et al., 2007).  As such, one of the goals of an optimal neural electrode 
biomaterial includes a reduced amount of glial activation which is linked to the increased 
fibronectin adsorption.  This study showed the rate of fibronectin and collagen adsorption was 
higher on both of the nanopatterned surfaces compared to the non-patterned surface, although the 
amount of adsorbed protein was not always greater.  In fact, there was significantly less 
fibronectin adsorption on the 3600 pattern compared to the 1800 pattern, non-pattern and 
PMMA.  These results suggest that although the protein is adsorbing faster on the nanopattern 
surfaces, the nanopattern features on the 3600 pattern substrate may inhibit the amount of protein 
adsorbed.   
Protein adsorption facilitates the cellular interaction with the substrate surface.  The 
number and strength of cells adhered to a substrate is inherently affected by the level of protein 
adsorption (Alaerts et al., 2001; Dupont-Gillain et al., 2004; Ni et al., 2009; Salakhutdinov et al., 
2008).  Surface topography has been shown to either directly influence the cell response, or 
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indirectly effect the cell responses through the affects they have on the adsorption of proteins 
(Kamath et al., 2008; Kriparamanan et al., 2006; Tang et al., 1998; Thevenot et al., 2008).  Cell 
adhesion results comparing substrates coated with fibronectin, collagen or no protein revealed 
that on all protein coated substrates, there was significantly more cell adhesion on both of the 
protein coated substrates compared to the substrates without any protein coating.  The results 
demonstrate that the adsorption of both fibronectin and collagen decreased the contact angle of 
the substrates, therefore making them more hydrophilic, which is consequently desirable for cell 
attachment.  Furthermore, it was found that there were significantly fewer number of cells 
adhered on both of the nanopatterned surfaces coated with fibronectin compared to the non-
patterend, PMMA and the control.  In fact, the fibronectin coated 3600 pattern substrate had the 
least number of cells compared to all other substrates.  Similarly, Achyuta et al found that a 
decrease in fibronectin adsorption on the material surface resulted in a decrease in microglia 
attachment to that material because microglia adhesion on synthetic materials is known to be 
mediated by fibronectin (Achyuta et al., 2010).  Overall, the amount of collagen adsorption did 
not differ significantly between the patterned and non-patterned substrates.  However, the 
amount of cell adhesion on the collagen coated 3600 pattern was significantly less than the non-
patterned substrate.  The decrease of cell adhesion on both the fibronectin and collagen coated 
3600 pattern and 1800 pattern, compared to the non-pattern and control substrates, may be due to 
conformational changes occurring in the proteins as they adhere to the patterned surface.  Keller 
et al observed ultrahigh molecular weight polyethylene (UHMWPE) surface nanotopography 
alters the protein orientation and partially aligns single human plasma fibrinogen molecules 
(Keller et al., 2011).  Tang et al have done numerous studies analyzing the cell response to 
various coating of functional groups on material surfaces (Kamath et al., 2008; Tang et al., 1998; 
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Thevenot et al., 2008).  They found subsequent cellular responses were partially mediated by the 
surface chemistries of the materials due to the functional group coatings (Kamath et al., 2008; 
Tang et al., 1998; Thevenot et al., 2008).   
Activated astrocytes are characterized by hypertrophy, hyperplasia, upregulation of 
GFAP, increased formation of filaments, irregularly shaped nuclei (Buffo et al., 2010; Gervasi et 
al., 2008; Laird et al., 2008; Polikov et al., 2006; Polikov et al., 2005).  Nanotopography has 
been shown to affect the cells’ adhesion, morphology, alignment, proliferation, gene expression 
profiles and even prevent biofouling and contamination on the material’s surface (Kriparamanan 
et al., 2006).  This was evident in the presented study.  Relative gene expression of GFAP was 
the lowest on both patterned substrates compared to the non-patterned, PMMA and control 
substrates.  In fact, the 3600 pattern substrate had a decrease in GFAP over time, and had the 
lowest GFAP gene expression on day seven compared to all materials.  These results indicate 
that the nanopatterned PMMA substrates inhibit GFAP expression, with the 3600 pattern having 
the largest effect.  The MAP2k1 relative gene expression decreased over time with both of the 
pattern substrates; again have the lowest levels with the 3600 pattern by day seven.  These results 
imply that cells grown on the 3600 pattern are less hyperplasic within days indicating less 
astrocyte reactivity.  O’Keefe et al did a study on the effects of microgrooves on fibroblast gene 
expression (O'Keefe et al., 2001).  They found there were many initial gene changes and also 
down-regulation of gene response with time (O'Keefe et al., 2001). This was thought to happen 
due to the deformation in the cell and nucleus morphology (O'Keefe et al., 2001). 
Cell alignment generally means the polarization and elongation of the cells in the 
direction of the nanogrooves.  This is thought to be due to the rearrangements of the cytoskeleton 
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induced by the surface.  This study demonstrated that nanoscale patterning alters cell attachment 
and organization on surface.  By day one in culture cells on the pattern surfaces began to orient 
and align themselves along the nanopattern.  Curtis et al observed that when fibroblasts were 
seeded onto a nanostructured surface, the first event which took place was the cytoskeleton 
arrangement (Curtis, 2005; Curtis et al., 2004; Das et al., 2008; Fok-Seang et al., 1998).   Within 
the first five minutes post seeding, the actin aggregation occurred then within 20 minutes the 
microtubules aligned (Curtis, 2005; Curtis et al., 2004; Das et al., 2008; Fok-Seang et al., 1998).  
Furthermore, the differences found in gene expression between the nanopatterned and non-
patterned surfaces may be due to the rearrangements of the cytoskeleton occurring from adhering 
and aligning along the nanopatterned surface.  The transductions of mechanical forces cause the 
changes in gene expression.  Studies have shown mechanical forces directly correlate with gene 
expression and protein production (Asparuhova et al., 2009; Avvisato et al., 2007; Sarasa-
Renedo and Chiquet, 2005).  The mechanical forces occurring in vivo are thought to cause 
shifting in the ECM, therefore stimulating the cells to establish new contact with the ECM 
(Asparuhova et al., 2009; Chiquet et al., 2003; Sarasa-Renedo and Chiquet, 2005).  The physical 
stretching of the cell is then thought to expose previously hidden sites thereby resulting in altered 
responses (Asparuhova et al., 2009; Chiquet et al., 2003; Sarasa-Renedo and Chiquet, 2005).     
Distinctive results were found comparing the protein and cell response to the 3600 
pattern versus the 1800 pattern.  The 3600 pattern had less fibronectin and collagen adsorption, 
but at a higher rate of adsorption compared to the 1800 pattern.  There were fewer cells attached, 
proliferating and viable on the 3600 pattern compared to the 1800 pattern.  Finally, the relative 
GFAP and MAP2k1 gene expression was lower on the 3600 pattern compared to the 1800 
pattern.  These results indicate that the addition of surface topography must be explicit.  In fact, 
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studies have shown there are specific features sizes that induce special protein and cell reactions 
to the surface topography.   Petrossians et al showed that there was less adhesion and 
proliferation of astrocytes and fibroblasts on carbon nanofibers compared to microcarbon fibers 
(Petrossians et al., 2011; Rose et al., 1985).  Studies done by Shain et al found that astrocytes 
prefer to grow and adhere onto patterned surfaces of varying dimensions over smooth silicon 
surfaces in vitro (Kriparamanan et al., 2006; Szarowski et al., 2003). Seil et al studied the 
astrocyte adhesion and proliferation on zinc oxide nanoparticle polyurethane composites.  They 
found that there was a significant decrease in astrocyte adhesion and proliferation when there 
were more zinc oxide nanoparticles on the surface (Rose et al., 1985).  Collectively, it has been 
shown that cells are very particular to the surface they grow on; their response varies with minute 
feature alterations on the nanoscale.  Our study confirmed this marvel, exhibiting that an increase 
of 278nm in nanogroove width elicits varied protein and cell response.   
The mechanism involved with the cellular response to a nanopatterned surface is not well 
understood.  As previously mentioned, it is thought that the effects of the surface topography 
either directly influence the cell response, or indirectly effect the cell responses through the 
affects they have on the adsorption of proteins (Kriparamanan et al., 2006).  This study showed 
that both of these thoughts are accurate.  The cells’ proliferation, viability, adhesion, alignment 
and gene expression without protein adsorption and determined the nanopattern affected all of 
these cell responses was studied.  Furthermore, the protein adsorption, rate of adsorption, the 
cells’ adhesion and alignment on surfaces coated with proteins was examined.  It was determined 
that the protein and cell response was affected.  Indeed, it was demonstrated that protein coating 
on the surface increased cell adhesion and alignment, however, this occurrence was found 
regardless of protein coating.  Nanoscale surface features better imitate the nanoscale protein rich 
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environment of the ECM found in vivo (Rose et al., 1985).  The surface area of the nanoscale 
roughness samples is much larger, therefore allowing for more interaction between the cells and 
proteins on the surface (Rose et al., 1985).  Moreover, nanomaterials have more of a surface 
energy than flat surface due to their increase in grain boundaries.  This increase of surface energy 
is thought to not only increase the amount of protein adsorption, but the conformation of the 
proteins adsorbed as well (Rose et al., 1985).   
6.5 Conclusion 
Results of this study agree with current literature showing that topography effects protein 
and cell behavior.  It was found that both proteins and cells were affected by the nanopatterning 
of PMMA.  The aim of the current study was to determine optimal feature sizes for neural 
electrode fabrication, which was defined as eliciting a non-reactive astrocytic response.  The 
3600 patterned surface was determined to elicit less of a response as compared to the other 
patterned and non-patterned surfaces.  The surface instigated cell alignment along the 
nanopattern, less protein adsorption, less cell adhesion, proliferation and viability, inhibition of 
GFAP and MAP2k1 compared to all other substrates tested.  Further investigation applying these 
feature sizes in an in vivo setting is required to fully appreciate the beneficial effects of this 
specific nanopatterned surface.   
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CHAPTER 7 
7.1 Comparative Assessment of Iridium Oxide and Platinum Alloy Wires using an in vitro 
Glial Scar Assay  
 
There has been great advancement in neural prostheses research over the last 35 year 
(Mian et al., 2005).  Currently, over 200,000 devices are implanted into patients (Gobbels et al., 
2010; Mian et al., 2005).  The majority of these devices are either implanted into the spinal cord 
or a peripheral nerve.  To date, there are limited clinical microelectrodes that are implanted in the 
brain (Mian et al., 2005).  The long-term effect of chronically implanted electrodes is the 
formation of a glial scar made up of reactive astrocytes and the matrix proteins they generate 
(Polikov et al., 2005; Seil and Webster, 2008).  The prolonged excitation of neurons due to the 
over stimulation of electrode materials has shown to cause damage to the electrode and the 
neural tissue (Agnew et al., 1986; Cogan et al., 2004a; Negi et al., 2010b).  Tissue damage is 
thought to occur from either initial bio-incompatibility of the electrode materials or the result of 
electrical overstimulation of the material which causes leaching of toxic by-products from the 
electrode materials into the physiological environment (Cogan et al., 2004a; McCreery et al., 
1990; Negi et al., 2010b).   
Ideal electrode materials should have low impedance, high capacitance and should be 
able to deliver a charge to the interface and tissue without inducing chemical reactions on the 
electrodes (Kotov et al., 2009; Negi et al., 2010a; Negi et al., 2010b).  Higher charge injection 
capacity is thought to lower the potential required for stimulation, thus reducing the injury at the 
stimulation site (Negi et al., 2010a).  Higher charge injection capacity (mC/cm2) requires less 
area to transfer charge, therefore allowing neural electrodes to be smaller in size (S. Negi, 2009).  
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Smaller electrodes would have many advantages such as increasing neural selectivity, decreasing 
the immune system response and reducing neural damage (Kotov et al., 2009; S. Negi, 2009).  
Currently, two of the most widely used conductive materials in neural electrodes are 
platinum and iridium oxide.   Platinum is widely used for neural stimulation because it is 
resistant to corrosion and can transfer charge using reversible reactions that do not harm tissue 
(Merrill et al., 2005; Petrossians, 2011).  Platinum has charge injection capacities in the range of 
50-150µC/cm2 (Cogan et al., 2005; Negi et al., 2010a; Rose and Robblee, 1990).  Recent studies 
have shown platinum iridium alloys are more desirable biomaterial for electrodes due to their 
larger charge injection capacities (300 µC/cm2), lower electrochemical impedance, and increased 
mechanical properties compared to pure platinum (Kotov et al., 2009; Negi et al., 2010a; 
Petrossians, 2011; Petrossians et al., 2011; Rose and Robblee, 1990).  Iridium oxide has some 
advantages over platinum for neural stimulation electrode material due to its higher charge 
injection capacity, resistance to corrosion and lower impedance (Negi et al., 2010a; Negi et al., 
2010b; S. Negi, 2009).  Moreover, iridium oxide is well known for its reversible redox reactions 
which significantly increase the charge injection capacity to the range of 2-3 mC/cm2 (Cogan et 
al., 2005; Kotov et al., 2009; Negi et al., 2010b).   
There have been numerous studies on the mechanical and electrical properties of 
materials used in neural electrode devices.  Studies have proven that there is neuronal tissue 
damage due to prolonged stimulation of electrode materials.  However, it is unclear whether the 
damage is strictly due to the electrical stimulation, or bio-incompatibility of the electrode 
materials.  There is a huge gap in research studying the biocompatibility of neural electrode 
biomaterials (Ereifej et al., 2011).  After two decades of in vivo testing, the mechanism depicting 
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the failure of chronic neural electrodes was still unclear.  Moreover, studies involving in vivo 
implantation are expensive, time consuming, and almost impossible to control at a molecular 
level in which the mechanisms of failure can be understood (Achyuta et al., 2010; Polikov et al., 
2006; Polikov et al., 2005).  Recently, Polikov et al adapted an in vitro glial scar assay in order to 
assess the inflammatory response on a molecular level (Achyuta et al., 2010; Polikov et al., 
2006).  They remarked on the benefits of having an in vitro system mimicking the effects of the 
in vivo world.  Polikov et al adapted an in vitro cell culture system developed by Hong et al 
(Polikov et al., 2006).  Hong et al used this model to test the neuroinflammatory mechanisms 
behind neurodegenerative diseases (Polikov et al., 2006).  This model allows for the dissection of 
the brain at a detailed cellular level; containing neurons, astrocytes, and microglia, which are 
believed to produce the “glial scar” (Achyuta et al., 2010; Polikov et al., 2006; Polikov et al., 
2005).   
Both platinum alloy and iridium oxide have been identified as good candidates as neural 
electrode biomaterials due to their mechanical and electrical properties, however, effect of glial 
scar formation for these two materials is lacking.  It is imperative to assess the biocompatibility 
of materials before employing them in neural electrode fabrication.  Recent work performed in 
our lab utilized a combination of techniques for characterizing the biocompatibility of cells in 
vitro on neural electrode materials (Ereifej et al., 2011).  In this study, we applied a glial scarring 
assay to observe the cellular reactivity to platinum alloy and iridium oxide wires in order to 
assess the biocompatibility based on previously defined characteristics.  Through real-time PCR, 
immunostaining and imaging techniques, we will advance the understanding of the 
biocompatibility of these materials.   
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7.2 Methodology 
7.2.1 Materials  
Platinum alloy wires (80% platinum and 20% iridium) were produced by California Fine 
Wire Company.  Platinum wires had a 20 µm diameter.  Iridium oxide thin films were deposited 
on platinum wires using a pulsed-DC magnetron (using an unbalanced, planar magnetron source 
model ST20 from AJA International, and plasma power supply, model MDX 1.5K from 
Advanced Energy) reactive sputtering technique in Ar/O2 plasma. The Ir sputtering target 
(Plasmaterials, INC) had a diameter of 2 inch (purity 99.9%). A thin titanium adhesion layer was 
deposited in the same sputtering process. Prior to deposition the chamber was evacuated to a 
base pressure of 10-7 Torr by a mechanical pump first and then by a cryogenic pump. The 
sputtering power was fixed at 150W with a pulsing frequency of 100 kHz and reverse bias 
duration of 2µsec. The oxygen flow rate was maintained at 8 sccm and the argon flow rate was 
maintained at 40 sccm. The sputtering pressure was maintained at 5mTorr. The amorphous films 
were sputtered at room temperature.  A Dektak profilometer was used to measure the thickness 
of the IrO2 thin film and was found to be 200 nm. Materials were washed using an Ultraomet 
2003 Sonic Cleaner (Buehler, Bluff, IL) in ethanol, followed by distilled water, for 15 minutes in 
each solvent.  Samples were autoclaved for 30 minutes at 121oC and sterilized under UV light.  
Sterilized wires were cut into 5mm pieces, of which one wire was placed into each well over the 
cultured cells.  Controls were the cells growing on the poly-d-lysine (MW 30-70k, Sigma-
Aldrich, St. Louis, MO,  P6407) coated glass wafers without wires.   
7.2.2 Surface Chemistry Characterization 
To characterize the surface composition of the elements found in IrO2, a high resolution 
x-ray photoelectron spectroscopy (XPS) using monochromatic AlKa radiation in a Perkin Elmer 
101 
 
 
model S500 XPS Spectrometer was used.  This technique was used to confirm iridium was 
present (Figure 39).    
 
 
Figure 39. A) High Resolution XPS on IrO2 wire. The y-axis displays the number of electrons measured, 
while the x-axis shows the binding energy of the electrons.  B) Iridium peak from XPS survey scan.  The 
composition of sputtered iridium oxide thin film was confirmed to be IrO2 by high resolution XPS scan.  
 
A 
B 
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7.2.3 Primary Mixed Neuronal Cell Culture 
The Wayne State University Institutional Animal Care and Use Committee approved 
experimental protocols described herein.  A mixed neuronal cell culture (including neurons, 
astrocytes and microglia) was isolated from Sprague-Dawley embryonic day 17 rat pups.  The 
mother rat was euthanized by rapid asphyxiation with carbon dioxide (CO2) gas; assurance of 
death was conducted by a thoracotomy. Rat pups were dissected out following Liu et al’s 
protocol and then decapitated (Liu and Hong, 2003).  Cortex tissues of the pups’ brain were 
dissected in sterile Hank’s Buffered Sodium Solution (HBSS) containing 1% penicillin-
streptomycin.  Following which, the tissues were dissociated and seeded at a density of 7×105 
cells/well.  Prior to seeding, 5mg of poly-d-lysine (MW 30-70k, Sigma-Aldrich, St. Louis, MO, 
P6407) was dissolved in 250mL of DNA/RNA free distilled water (sterilized by 0.22um filter).  
The poly-D-lysine was coated onto the samples (1ml/well) and incubated overnight at 37oC.  
This altered the surface charge allowing the neurons to adhere onto the surface.  The wells were 
then washed twice with sterile distilled water and once with sterile HBSS.  The cells were 
maintained in 56% minimal essential medium (MEM), 20% Dulbecco’s Modified Eagle’s 
Medium (DMEM), 10% fetal bovine serum (FBS), 10% horse serum (HS), 4% 
penicillin/streptomycin.  The samples were housed in a humidified incubator with the following 
setting conditions: 90% humidity, 5% CO2 and 37.8oC.   
7.2.4 Real Time PCR 
Real time PCR was used to measure gene expression from samples relative to the control.  
The total RNA from the cells was extracted on day one, four and seven post seeding with Trizol 
(Invitrogen, Carlsbad, CA) following the manufacturer’s protocol.  The RNA concentration and 
purity was determined using a spectrophotometer through UV absorbance at 260nm and 280nm.  
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Reverse transcriptase using the random primers converted the mRNA to a cDNA template using 
a thermal cycler (Mastercycler Gradient, Eppendorf, Hauppauge, NY).  For PCR analysis, we 
used cDNA equivalent to 40ng of total RNA.  Specific primer pairs (Table 5) for astrocyte 
activation, glial fibrillary acidic protein (GFAP) were employed.  As an internal control, we used 
the house-keeping gene glyceraldehyde-3-phosphate dehydrogenase (GAPDH).  The PCR master 
mix included 1 x SYBR® Green (Applied Biosystems, Foster City, CA), and forward and reverse 
primers (0.4µM each).  cDNA templates and master mix were read in a 96-well optical plate 
using a 7500 Fast Real-Time PCR System (Applied Biosystems, Foster City, CA).  The 
following profile was used: 50◦C for 2 min, 95◦C for 10 min, and 40 cycles of 95◦C for 15s and 
60◦C for 1 minute.  Threshold cycle (Ct) values for each sample and primer pair were obtained 
and analyzed with the delta-delta (∆∆) Ct method (Livak and Schmittgen, 2001; Schmittgen and 
Livak, 2008) in order to calculate the fold change (R) in each target gene.  The following 
equations were used: 
∆Ct = Ctsample − CtGAPDH 
∆∆Ct = ∆Cttest surface – ∆Ctcontrol surface 
R = 2−∆∆Ct 
Table 6. Primer sequences for real-time PCR used in glial assay studies. 
Cells Category Gene  Primer Sequence 
Primary 
brain cells 
Housekeeping gene GAPDH 5’-TGGCCTTCCGTGTTCCTACC-3’ (F) 
5’-AGCCCAGGATGCCCTTTAGTG-3’ (R) 
Activation gene GFAP 5’-GTTGTGTTCAAGCAGCCTGG-3’ (F) 
5’-CCAGTGAGTAAAGGTGACAG-3’ (R) 
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7.2.5 Immunostaining  
The mixed primary brain cell cultures were stained with fluorescent antibodies in order to 
image each cell type specifically.  At day seven post seeding, the cells were fixed in a 4% 
paraformaldehyde solution for 20 minutes at room temperature.  Following three rinses in 
1×PBS, the samples were incubated in a 0.25% Triton solution (in 1×PBS) for 20 minutes at 
room temperature (RT) in order to permeate the cell’s membrane and then rinsed three times 
with 1×PBS to ensure all of the detergent was removed.  After which, the cells were blocked for 
one hour in a 5% goat serum at RT.  Milli-Mark Pan Neuronal Marker (Millipore, Billerica, MA) 
was used to stain neurons (1:500 in 1×PBS), for two hours at 37oC.  Samples were washed with 
5% fetal bovine serum (FBS) blocking solution (in 1×PBS) for ten minutes each wash for a total 
of three washes.  Alexa Fluor 488 goat anti-mouse IgG (Abcam, Cambridge, MA) secondary 
antibody (1:2000 in 1×PBS) was applied for one hour in the dark at RT.  Cells were then washed 
three times with 1×PBS and blocked with 5% FBS for one hour in the dark at RT.  Astrocyte 
specific primary antibody, GFAP (Millipore, Billerica, MA) was used to stain astrocytes (1:1000 
in 1×PBS) for two hours at 37oC.  Cells were washed with 5% FBS three times before adding the 
secondary antibody for the astrocytes.  GFAP Alexa Fluor 555 goat anti-rabbit IgG (Invitrogen, 
Carlsbad,CA) secondary antibody (1:2000 in 1×PBS) was used for one hour in the dark at RT.  
Samples were washed three times with 1×PBS and blocked for one hour in 5% FBS at RT in the 
dark.  Triple staining of the nucleus was done using 2g/mL of 4',6-diamidino-2-phenylindole 
(DAPI; Sigma-Aldrich, St. Louis, MO) for 20 minutes at RT in the dark.  The samples were 
mounted on glass slides using ProLong Anti-Fade Gold reagent (Invitrogen, Carlsbad, CA) and 
viewed under a Zeiss Axio Observer Inverted Microscope (Carl Zeiss Inc).   
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7.2.6 Image Analysis 
Image J software was used to measure the scar thickness, mean GFAP and DAPI 
intensities around the wires.  Each image was first converted to an 8-bit grayscale, following 
which a threshold binary image was created.  The thickness of the scar was found by measuring 
the width, from the edge of the wire to the edge of the scar, on each side then averaged.  Grids 
made up of two rows, with eight boxes total (four boxes per row and the area of each box being 
100 µm2), were overlaid on top of the DAPI and GFAP images along the length of the wire.   
Only the area inside of the grid was used for measuring. The mean GFAP and DAPI intensities 
were measured using the same grid procedure.  The average area within the grid stained with 
either GFAP or DAPI respectfully was then measured using the analyze particles function.   
7.2.7 Statistical Analysis 
All of the data are presented as a mean ± standard error of the mean.  Experiments were 
performed with samples sizes of three to five and repeated three independent times.  There were 
minimally 15 samples analyzed per group.  PASW software (version 18.0) was utilized for 
statistical analysis.  A nonparametric statistical analysis was used to test for statistically 
significant differences between the different material groups over time for the RTPCR, scar 
thickness and imunostaining studies.  Parametric statistical methods could not be completed due 
to insufficient power from a small sample size, mean values were either not normally distributed 
or the variances of the data were not heterogeneous.  The exact tests were conducted in order to 
be able to make reliable inferences by computing exact p values for a very wide class of 
hypothesis tests, including one-, two-, and K sample tests, tests for unordered and ordered 
categorical data, and tests for measures of association.   
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7.3 Results 
7.3.1 Scar Thickness  
Results demonstrated that scar thickness decreased around both the platinum alloy and 
the IrO2 wires with time (Figure 40).  Compared to day one, the scar thickness around the IrO2 
wires had significantly decreased (p<0.01) by days four and seven.  Scar thickness around the 
platinum alloy wires also had a significant decrease in thickness (p<0.01) by day seven 
compared to days one and four.  When comparing the materials, it was found that the scar 
thickness around the platinum alloy wires was significantly less (p<0.05) on day seven compared 
to the IrO2 wires.   
 
A 
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Figure 40. A) Phase contrast images of glial scar over time.  B) Scar tissue thickness measurement. Both 
IrO2 and Pt wires had a decrease in scar thickness.  IrO2 had a thicker scar on days one and seven 
compared to Pt.  *p<0.01 data compared to IrO2 on day one, +p<0.01 data compared to platinum alloy on 
day seven, ¤p<0.05 data compared to IrO2 on day seven  
 
7.3.2 Relative Gene Expression 
Cells cultured with IrO2 wires had significantly higher (p<0.01) GFAP relative gene 
expression on day one compared to both the control and those cultured with platinum alloy wires 
(Figure 41).  There was not any statistical significance found on days four and seven.  However, 
it is important to note that cells cultured with platinum alloy wires had less GFAP gene 
expression compared to IrO2 wires on all three days.   
B 
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Figure 41. RTPCR GFAP relative gene expression.  The control is represented by the red horizontal line.  
+p<0.01 compared to platinum alloy on day one, ¤p<0.01 compared to control on day one.  Cells cultured 
with platinum alloy wires had overall lower levels of GFAP expression compared to IrO2 wires.   
7.3.3 Immunostaining   
Immunostaining of neuronal cells’ nuclei and activated astrocytes revealed not only 
fewer activated astrocytes around platinum alloy wires, but fewer cells overall compared to IrO2 
wires (Figure 42).  The mean GFAP fluorescence intensity was significantly elevated (p<0.01) in 
cell cultures with IrO2 wires compared to cultures with platinum alloy wires and control cultures 
without any wires (Figure 43).  Control cultures had significantly lower (p<0.01) GFAP mean 
intensities compared to cell cultures with either the platinum alloy or IrO2 wires.  The mean 
DAPI intensity of cells cultured with platinum alloy wires was significantly lower (p<0.01) 
compared to control and IrO2 wires cultures (Figure 44).     
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Figure 42. Triple fluorescent labeling with DAPI staining cell nuclei (blue), GFAP staining astrocytes 
(red), and Millimark staining neurons (green).  Images were taken at day seven. 
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Figure 43.   Mean GFAP fluorescence intensity within a distance of 100 µm on either side of the wire on 
day seven.  +p<0.01 data compared to control (no wire), ¤p<0.01 data compared to platinum alloy.  
Platinum alloy wires had the lowest mean GFAP intensity  
 
Figure 44.   Mean DAPI fluorescence intensity within a distance of 100 µm on either side of the wire on 
day seven.  +p<0.01 data compared to platinum alloy.  Platinum alloy wires had the lowest mean DAPI 
intensity. 
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7.4 Discussion 
There is limited information assessing the biocompatibility of neural electrode materials, 
especially the biomaterials used to electrically stimulate the neurons, such as iridium oxide and 
platinum alloys.  In fact, the few studies involving cells to calibrate biocompatibility of these 
materials have only utilized neurons (Gobbels et al., 2010; Khan and Newaz, 2010; Lee et al., 
2003; Thanawala et al., 2007).  These types of studies have classified platinum alloys and 
iridium oxide as biocompatible on the basis that neurons grew on top of the materials, usually 
requiring a protein coating such as poly-d-lysine (Gobbels et al., 2010; Khan and Newaz, 2010; 
Lee et al., 2003; Thanawala et al., 2007).  Although it is imperative for the electrically 
stimulating biomaterial to attract neurons, it is equally crucial for the material to also evade glial 
cell activation and prevent the formation of glial scars.   
It has been established that the inflammatory response within the brain tissue is 
characterized by the presence of reactive astrocytes and microglia, which form the glial scar 
around the implanted electrode (Kidambi et al., 2010; Szarowski et al., 2003).  Furthermore, 
activated astrocytes are identified as hypertrophic, hyperplasic, have an upregulation of 
intermediate filament GFAP and filament formation (Gervasi et al., 2008).  This study employed 
the distinguished characteristics of an inflammatory response in order to determine the 
biocompatibility of platinum alloy and iridium oxide wires for the use of neural electrode 
fabrication.  We measured the thickness of the scar tissue around the wires, the relative gene 
expression of GFAP, the fluorescence intensity of GFAP and DAPI as markers of 
biocompatibility.   
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The glial scar functions to encapsulate the electrode, separating the damaged brain tissue 
and the foreign device from the undamaged, healthy tissue (Polikov et al., 2005).  This normal 
defensive mechanism leads to an increasing distance between the electrode and its target neurite 
processes.  Thus, increasing the impedance of the electrode and decreasing signal strength 
(Polikov et al., 2005).  The strength and quality of the recorded electrical signal is determined by 
the location of the neuron in relation to the electrode recording sites.  In order to maintain a 
recording and accurately observe action potentials, the maximum distance between neuron and 
electrode, commonly referred to as the “kill zone”,  can only be between 50-100 µm (McCreery 
and Agnew, 1983; Polikov et al., 2005; Turner et al., 1999; Wang et al., 2011).     
In vivo and in vitro studies have shown over time, the glial scar decreases in thickness, 
however it becomes denser and more organized (Achyuta et al., 2010; Polikov et al., 2006; 
Szarowski et al., 2003; Turner et al., 1999).  We found a similar trend with both the platinum 
alloy and IrO2 wires; the scar thickness decreased inversely proportional with time, therefore 
making this in vitro data credible.  Interestingly, the glial scar formed around either the platinum 
alloy or IrO2 wires in this study was a fraction of the size (40 - 60µm) compared to glial scars 
found in previous literature (50 - 600µm) both in vivo (Szarowski et al., 2003; Turner et al., 
1999) or in vitro using comparable cell seeding densities (Polikov et al., 2006; Polikov et al., 
2009).  The compactness of the scar thickness measured in this study implies less of an 
inflammatory response.  Although in comparison to each other, the platinum alloy wires have 
proven to be more biocompatible, the IrO2 wires are not necessarily bio-incompatible.   
Results of the RT-PCR and GFAP immunostaining validated one another.  The RT-PCR 
findings demonstrated less GFAP relative gene expression from astrocytes in culture with the 
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platinum alloy wires compared to the IrO2 wires on all three time points.  Moreover, the mean 
GFAP fluorescence intensity was lower with the platinum alloy wires compared to the IrO2 
wires.  Increased GFAP expression is an indication of reactive astrocytes.  Studies have shown 
that the molecular composition of the glial scar and the production of inhibitory molecules by 
reactive astrocytes impair axon regeneration (2003; Seil and Webster, 2008).  Astrocytes in the 
glial scar are known to upregulate inhibitory molecules, such as, chondroitin sulfate 
proteoglycans (CSPGs), tenascin, Semaphorin 3, ephrin-B2, and slit proteins which play a role in 
the CNS axons inability to regenerate (Fitch and Silver, 2008).  It has been shown that reactive 
astrocytes secrete proteoglycans that inhibit the growth of neuritis in injured spinal cord and 
brain models (Griffith and Humphrey, 2006).   These results suggest that there were fewer 
activated astrocytes around the platinum alloy wires, thus signifying platinum alloy wires to be 
more biocompatible compared to IrO2 wires.   
Furthermore, platinum alloy wires had the lowest mean DAPI fluorescence intensity 
compared to IrO2 wires.  This further validates the superior biocompatibility of platinum alloy 
wires compared to the IrO2 wires.  IrO2 wires having higher levels of DAPI intensity indicates 
the presence of more cells than around the platinum alloy wires.  Neurons make up less than 25% 
of the cells in the brain, which leaves the other 75% to be a combination of glial cells (Polikov et 
al., 2005).  Therefore, the majority of the cells around the wires are made up of astrocytes and 
microglia, both of which are undesirable to have around electrodes.  Studies have shown that 
increased proximity of glial cells to neural electrodes are directly correlated with increased glial 
scarring and reduced neuron viability (Achyuta et al., 2010; Biran et al., 2005; Szarowski et al., 
2003; Turner et al., 1999).   
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Previous studies comparing the mechanical and electrical properties of platinum alloys to 
IrO2 always depict IrO2 as the superior material.  However, comparison of the biocompatibility 
of these two materials reveals platinum alloys to be superior.  Thanawala et al observed the 
adhesion of cortical neurons isolated from rat embryo brain onto platinum and IrO2 film strips 
(Thanawala et al., 2007).  They found poor cell attachment on IrO2 surfaces compared to 
platinum surfaces, thus indicating superior biocompatibility of the platinum surface.  Potential 
differences between the documented studies, such as utilizing neurons alone or the use of mixed 
cell cultures, appear to confirm the importance of the glial cells when evaluating material 
compatibility. 
7.5 Conclusions 
It is well known that when compared by electrical properties, such as impedance and 
charge injection capacity, iridium oxide has the advantage with lower impedance and a higher 
charge injection capacity compared to platinum, thus making it more favorable for neural 
electrode fabrication. However, results of this study demonstrate that although the electrical 
properties may be better, iridium oxide wires exhibited a more significant reactive response as 
compared to platinum alloy wires.  Cells cultured with platinum alloy wires had less GFAP gene 
expression, lower average GFAP intensity, and smaller glial scar thickness.  Collectively, these 
results indicated that platinum alloy wires were more biocompatible than the iridium oxide wires.  
Future research involving functionality of neurons as well as further glial scar assessment will 
substantiate our current findings.   
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CHAPTER 8 
8.1 Assessment of Organotypic Brain Slice Response on Nanopatterned 
Polydimethylsiloxane Surface 
 
A long-term effect of chronically implanted neural electrodes is the formation of a glial 
scar made up of reactive astrocytes, microglia and the matrix proteins they generate (Polikov et 
al., 2005; Seil and Webster, 2008).  The initial response to implanted electrodes is an acute 
neuroinflammation mediated by microglia followed by astrocyte reactivity, which leads to 
astrogliosis (Rao et al., 2012; Sofroniew and Vinters, 2010).  Studies have shown that a variety 
of cytokines are involved with the initial and modulation phases of reactive astrogliosis (Farina 
et al., 2007; John et al., 2003; Liberto et al., 2004; Rao et al., 2012).  These cytokines include 
interleukin-1beta (IL-1β), tumor necrosis factor alpha (TNFα), and transforming growth factor 
beta 1 (TGFβ1).  Astrocytes express receptors to this signaling molecules and their binding 
results in an astrocytic reactive response (Farina et al., 2007; John et al., 2003; Liberto et al., 
2004; Rao et al., 2012).  In addition to receiving these signals, astrocytes also can generate and 
release cytokines such as IL-1β and TNFα which promote neurotoxicity whereas TGFβ1 acts as 
a neuroprotective (Farina et al., 2007; John et al., 2003; Liberto et al., 2004; Rao et al., 2012). 
Another known marker for activated astrocytes is an upregulation of intermediate filament, glial 
fibrillary acidic protein (GFAP) (Gervasi et al., 2008; Polikov et al., 2006; Polikov et al., 2005; 
Szarowski et al., 2003; Turner et al., 1999).  IL-1β, TNFα, and TGFβ1 can be expressed by both 
microglia and astrocytes (Farina et al., 2007; John et al., 2003; Liberto et al., 2004; Rao et al., 
2012).  The acute neuroinflammatory response is typically short-lived and unlikely to be harmful 
to neuronal survival (Glass et al., 2010; Rao et al., 2012; Yoles et al., 2001).  The acute response 
can be resolved by a negative feedback mechanism resulting in reduced levels of IL-1β and 
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TNFα and increased levels of TGFβ1 (Liberto et al., 2004; Moolwaney and Igwe, 2005; Rao et 
al., 2012).  Acute neuroinflammation is considered beneficial to the CNS, because it prevents 
further tissue destruction and contributes to repairing the damaged tissue (Liberto et al., 2004; 
Rao et al., 2012).  Although the acute response is considered beneficial to the CNS, if not 
resolved, it will transform into a chronic response thus rendering in the formation of a glial scar 
around the implanted electrode.  Therefore, the chronic presence of the electrode results in glial 
scarring around the implantation site which consequently impedes the electrode signal.  One of 
the goals of neural electrode fabrication is to design a material that minimizes this acute 
neuroinflammation. 
Current scientific strategies to inhibit the initiation of glial scarring around a chronic 
device range from altering the geometry, roughness, size, shape and materials of the device (Grill 
et al., 2009; Kotov et al., 2009; Kotzar et al., 2002; Szarowski et al., 2003).  In order to properly 
design a successful neural electrode, biomedical engineers strive to understanding of the cellular 
environment.   In vivo conditions comprise of cells living in the extracellular matrix (ECM) 
meshwork with a three-dimensional and high aspect ratio topographical textures on a micron and 
nano scale (Kriparamanan et al., 2006; Millet et al., 2010; Wu et al., 2006).  This 3-D 
environment provides cells the topographical cues required for them to differentiate and perform 
their specific functions.  Studies have shown that surfaces which mimic the nanotopography of 
the natural environment in vivo result in an improved biocompatible response (Curtis et al., 2004; 
Ding et al., 2010; Kotov et al., 2009; Millet et al., 2010; Zervantonakis et al., 2011).  
Nanotopography has been demonstrated to affect the cells’ morphology, alignment, adhesion, 
proliferation, gene expression profiles and even prevent biofouling and contamination on the 
material’s surface (Curtis, 2005; Curtis et al., 2004; Das et al., 2008; Fok-Seang et al., 1998; 
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Kriparamanan et al., 2006).  Topography affects gene expression of cytokines, growth factors, 
signaling molecules, and cytoskeleton-linked molecules (Kriparamanan et al., 2006).  Studies 
utilizing nanotopography with neural electrode materials have primarily focused on surface 
alterations of the active sites on the conducting material (Brunetti V, 2010; Gobbels et al., 2010; 
Negi et al., 2010a). Negi et al studied how increasing the surface area available for neuronal 
contact would  improve the spatial resolution and selectivity (Negi et al., 2010a).  Other studies 
examined the effect nanotopography has on glial cells, specifically on the reduction of the glial 
cells inflammatory response (Kotov et al., 2009; Pennisi et al., 2011; Pennisi et al., 2009).   
In the present study, nanopatterning of polydimethylsiloxane (PDMS) was attempted as a 
method for reducing the inflammatory response of glial cells.  PDMS elastomer is a standard 
material that is commonly used in studies involving topographical surface modifications due to 
its optimal physical properties.  PDMS is an inexpensive, highly viscoelastic, hydrophobic 
polymer with fairly low surface energy and thermal stability (Berdichevsky et al., 2010; Choi et 
al., 2009; H. Makamba, 2003; Millet et al., 2007; Zervantonakis et al., 2011).  PDMS provides 
easy release from the patterned substrate mold during processing which gives it the advantage of 
rapid prototyping capabilities and the ability to fabricate complex patterns down to the 
nanometer scale (Choi et al., 2009; H. Makamba, 2003; Millet et al., 2007; Zervantonakis et al., 
2011).  Moreover, devices fabricated with PDMS have been useful for biological studies due to 
their ease of fabrication, high gas permeability, optical transparency, and low water permeability 
of the structures formed from this material (David C Duffy, 1999; H. Makamba, 2003; Millet et 
al., 2007; Samuel K. Sia, 2003; T. C. Merkel, 2000).  Recently, devices fabricated with PDMS 
have been incorporated as structural components for patterning neuronal growth in culture and 
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studying the neural circuit physiology (Berdichevsky et al., 2009; Berdichevsky et al., 2010; 
Hanson et al., 2009; Millet et al., 2007).   
A unique feature of this study is the use of in vitro brain slice cultures (organotypic 
cultures) in order to more accurately depict the native response.  Organotypic cultures are used 
due to their ability to retain circuit architecture, connectivity and physiology specific to their in 
vivo origin (Berdichevsky et al., 2009; Morin et al., 2006).  Therefore, this culture system has 
many advantages over the traditional monoculture in vitro biocompatibility testing methods 
(Berdichevsky et al., 2009; Morin et al., 2006).  The aim of the present study was to determine 
whether nanotopography can reduce inflammatory markers typically resultant from neural 
electrode implantation.  The uniqueness of this in vitro model lies with the assumption that the 
slicing of the organotypic brain tissue elicits the typical injury found with neural electrode 
insertion.  PDMS was spin coated on nanopatterned substrates, peeled and rolled into cylindrical 
pins in order to comply with the 3D geometry of neural electrodes.  Thereafter, PDMS pins were 
placed in organotypic cultures for glial cell examination.  Specifically, observation of cell 
alignment and surveillance of GFAP, IL-1β, TNFα, and TGFβ1 gene expression around the 
PDMS pins was performed.   
8.2 Methodology  
8.2.1 Material Fabrication 
The method of nanoimprint lithography (NIL), otherwise known as hot embossing was 
utilized to create the nanopatterned surface.  Specifically, the JenOptik HEX03 hot embossing 
system (SSIM laboratory at Wayne State University) was used.  Goodfellow UV-grade PMMA 
was the substrate.  The processing temperature was 105-195°C and the applied controllable force 
was 300N – 3kN.  Molds were purchased from Edmund Optics (Barrington, NJ); reflective 
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holographic grated mold was used to make the patterned substrate with a period of 3600 
grooves/mm, and a flat mirror mold was used for the non-patterned surface.  The embossed 
substrates were cut into 1cm2 wafers.  PDMS was spin coated onto the PMMA wafers using a 
spin coater from Laurell Technologies Corporation (model: WS-650-23; North Wales, PA).  The 
PDMS was purchased from Dow Corning, (Midland, MI; Sylgard 184 Elastomer kit) and 
prepared by mixing Sylgard 184 Silone Elastomer base and Sylgard 184 Silone Eastomer Curing 
agent (10:1, w/w).  A 500 µl droplet was placed on the PMMA wafer.  The program was set at 
500rpm for five seconds and 1500rpm for 30 seconds.  The samples were then baked at 60oC for 
one hour.  After cooling, the PDMS was peeled from the PMMA wafer and rolled around a 23 
gauge needle to make cylinder pins, with the patterned side on the outside (Figure 45).  PDMS 
samples were sterilized by washing with 70% ethanol and distilled water and left under UV light 
for one hour.   
120 
 
 
 
Figure 45.  Schematic representation of material fabrication.  Shown here is an example using the 
nanopatterned substrate; the same steps were used to make the non-patterned samples. 
121 
 
 
8.2.2 Atomic Force Microscopy 
The dimensions of the nanopatterned PDMS substrates were characterized by Dimension 
3100 AFM (VEECO) in the tapping mode in ambient air. The height, amplitude, and phase 
images were obtained using silicon tapping tips (nanoScience Instruments, VistruaProbes T300) 
with resonance frequency of 300 kHz and tip radius less than 10 nm. The scan rate was 1–3 
Hz. Height images are plane-fit in the fast scan direction with no additional filtering operation. 
The dimensions of the nanopattern structure were determined using the sectional height analysis 
command (Nanoscope 5.30r3sr3) by manually measuring the lateral diameters and vertical 
heights of 3 - 5 different spots on each sample (Figure 46).  Due to the viscosity of the PDMS 
solution, the dimensions of the PDMS nanopattern were smaller than the hot embossed 
nanopatterned PMMA substrates (Table 6).   
                            
              
Figure 46.  (A) AFM of patterned PDMS substrate.  (B) SEM of patterned PDMS substrate.  (C) 
Schematic of patterned dimensions; “D” refers to depth, “R” refers to width of ridge, and “G” refers to 
width of groove. 
 
A 
C 
B
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Table 7.  Dimensions of nanopatterned substrates.  PDMS dimension are reported as mean ± standard 
deviation. 
  
Depth 
(nm) 
Width of ridge 
(nm) 
Width of groove 
(nm) 
PMMA 200 277 277 
PDMS 15 ± 2 117 ± 11 170 ± 16 
 
8.2.3 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) was utilized to image the cells and brain tissue on 
the substrate surface.  In particular, the Environmental SEM Quanta FEG 450 (FEI Company, 
Hillsboro, OR) was used at an operating high voltage of 10kV and pressure of 5.5 Torr.  On day 
seven, samples were fixed in a 4% paraformaldehyde solution for 30 minutes at room 
temperature (RT).  Following three rinses in 1×PBS, the samples were then washed in distilled 
water in order to remove salt crystals from the PBS.   
8.2.4 Brain Slice Culture  
The Wayne State University Institutional Animal Care and Use Committee approved 
experimental protocols described herein.  Sprague-Dawley postnatal five day old pups were used 
for brain slicing.  Pups were euthanized by decapitation.  Brains were removed and placed in ice 
cold dissection media made up of Hank’s Buffered Sodium Solution (HBSS) containing 1% 
penicillin-streptomycin and 600M µL-Glutamine.  Following which, the dissected brains were 
coated in a 4% agarose gel for slicing.  Whole brain tissue slices, at a thickness of 400nm, were 
made using a Leica VT 10005 Vibrotome Line (Leica, Buffalo Grove, IL).  Brain slices were 
grown on Millipore Millicell cell culture inserts (Millipore, Billerica, MA(Smeal et al., 2007).  
Brain tissue slices were maintained in 50% minimal essential medium (MEM), 1% penicillin-
streptomycin, 25% Fetal Bovine Serum (FBS) and 25% dissection media.  The tissues were 
housed in a humidified incubator with the following setting conditions: 90% humidity, 5% CO2 
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and 37.8oC.   Culture media was changed every two days.  PDMS pins were placed on the brain 
tissue slices (Figure 47) immediately after tissue slices were set in the cell culture inserts, with 
controls being tissue slices growing without PDMS pins.   
 
Figure 47.  Phase contrast image of PDMS pin lying on top of a brain tissue slice.  Image was taken on 
day seven of the nanopatterned PDMS pin. 
8.2.5 Immunostaining Brain Slices 
Brain slice tissues were stained with fluorescent antibodies in order to image astrocyte 
and cell nuclei attachment on the PDMS samples.  At day seven, the cells were fixed in a 4% 
paraformaldehyde solution for 30 minutes at room temperature.  Following three rinses in 
1×PBS, the samples were incubated in a 5% blocking buffer (4.9% gelatin, 94% 1×PBS, 1% of 
2% Na azide, and 0.1% triton) for one hour at room temperature (RT).  Astrocyte specific 
primary antibody, GFAP (Millipore, Billerica, MA) was used to stain astrocytes (1:100 in 
blocking buffer) overnight at 4oC.  Brain sections were washed with 1×PBS three times before 
adding the secondary antibody for the astrocytes.  GFAP Alexa Fluor 555 goat anti-rabbit IgG 
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(Invitrogen, Carlsbad,CA) secondary antibody (1:100 in blocking buffer) was used for one and a 
half hours in the dark at RT.  Samples were washed three times with 1×PBS.   The samples were 
mounted on glass slides using ProLong Anti-Fade Gold with DAPI reagent (Invitrogen, 
Carlsbad, CA) to stain the cell nuclei.  Samples were viewed under a Zeiss LSM-510 META 
NLO Laser Scanning Confocal Microscope (Carl Zeiss Inc).   
8.2.6 Real Time PCR 
Real time PCR was used to measure gene expression from samples relative to the control.  
The total RNA from the tissues was extracted on days one and seven with Trizol (Invitrogen, 
Carlsbad, CA) following the manufacturer’s protocol.  The RNA was then purified using RNeasy 
MinElute Cleanup kit and RNase-Free DNase kit (Qiagen, Valencia, CA).  The RNA 
concentration and purity was determined using a NanoDrop (Thermo Scientific, Wilmington, 
DE).  Reverse transcriptase using the random primers converted the mRNA to a cDNA template 
using a thermal cycler (Mastercycler Gradient, Eppendorf, Hauppauge, NY).  For PCR analysis, 
we used cDNA equivalent to 40ng of total RNA.  Specific primer pairs (Table 7) for astrocyte 
activation, glial fibrillary acidic protein (GFAP) and cytokines for inflammation, transforming 
growth factor beta 1(TGFβ1), interleukin 1 beta (IL1β) and tumor necrosis factor alpha (TNFα) 
were used.  As an internal control, we used the house-keeping gene glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH).  The PCR master mix included 1×SYBR® Green (Applied 
Biosystems, Foster City, CA), and forward and reverse primers (0.4µM each).  cDNA templates 
and master mix were read in a 96-well optical plate using a 7500 Fast Real-Time PCR System 
(Applied Biosystems, Foster City, CA).  The following profile was used: 50◦C for 2 min, 95◦C 
for 10 min, and 40 cycles of 95◦C for 15s and 60◦C for 1 minute.  Threshold cycle (Ct) values for 
each sample and primer pair were obtained and analyzed with the delta-delta (∆∆) Ct method 
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(Livak and Schmittgen, 2001; Schmittgen and Livak, 2008) in order to calculate the fold change 
(R) in each target gene.  The following equations were used: 
∆Ct = Ctsample − CtGAPDH 
∆∆Ct = ∆Cttest surface – ∆Ctcontrol surface 
R = 2−∆∆Ct 
 
Table 8. Primer sequences for real-time PCR used in nanopatterned PDMS studies. 
Cells Category Gene  Primer Sequence 
Organotypic 
Brain Slice 
Tissue 
Culture 
Housekeeping gene GAPDH 5’-TGGCCTTCCGTGTTCCTACC-3’ (F) 
5’-AGCCCAGGATGCCCTTTAGTG-3’ (R) 
Activation gene 
 
Cytokine 
 
Cytokine 
 
Cytokine 
GFAP 
 
TGF-β1   
 
IL1β 
 
TNFα 
5’-GTTGTGTTCAAGCAGCCTGG-3’ (F) 
5’-CCAGTGAGTAAAGGTGACAG-3’ (R) 
5’- ACCAACTACTGCTTCAGCTC -3’(F) 
5’- TGTTGGTTGTAGAGGGCAAG -3’ (R) 
5’-TCCATGAGCTTTGTACAAGG-3’ (F) 
5’–GGTGCTGATGTACCAGTTGG-3’ (R) 
5’-AAATGGGCTCCCTCTCATCA-3’ (F) 
5’-AGCCTTGTCCCTTGAAGAGA-3’ (R) 
 
8.2.7 Statistical Analysis 
All of the data is presented as a mean ± standard error of the mean.  Experiments were 
performed in triplicates and repeated three independent times.  PASW software (version 18.0) 
was utilized for statistical analysis.  A nonparametric statistical analysis was used to test for 
statistically significant differences between the different material groups over time for the 
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RTPCR.  Parametric statistical methods could not be completed due to insufficient power from a 
small sample size, mean values were either not normally distributed or the variances of the data 
were not heterogeneous.  The exact tests were conducted in order to be able to make reliable 
inferences by computing exact p values for a very wide class of hypothesis tests, including one-, 
two-, and K sample tests, tests for unordered and ordered categorical data, and tests for measures 
of association.   
8.3 Results 
8.3.1 Immunostaining  
Immunostaining of astrocytes and cell nuclei revealed cells grown on the nanopatterend 
PDMS pins grew in one general direction, while cells growing on the non-patterned PDMS pins 
grew in random orientation (Figure 48).  The nuclei of cells’ growing on the nanopatterned pins 
were elongated in the same direction as the astrocyte processes.  The nuclei of cells’ grown on 
the non-patterned pins were rounder and not following any particular or uniform direction.  
Moreover, the cell distribution did not seem to differ between both material surfaces, there were 
the same amount of cells on both nanopatterned and non-patterned pins.   
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Figure 48.  Confocal images at day seven of GFAP stained astrocytes and DAPI stained cell nuclei 
growing on (A) patterned PDMS pin (B) non-patterned PDMS pin. 
A 
B 
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8.3.2 SEM 
SEM images confirmed that the cells growing on the nanopatterned surface were aligning 
with the pattern (Figure 49).  As can be seen from the SEM images, cells on the nanopatterned 
surfaces were elongated along the pattern’s direction.  However, cells growing on the non-
patterend surface were randomly oriented on the surface.   
   
    
Figure 49. SEM images at day seven of cells growing on (A) nanopatterned PDMS pin.  Cells are 
growing along the nanopaterned lines.  (B) non-patterned PDMS pin. 
A 
B 
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8.3.3 Relative Gene Expression  
Cells cultured with non-patterned PDMS pins had significantly lower (p<0.01) GFAP 
relative gene expression on day one compared to the control (Figure 50).  There was not any 
statistical significance found with GFAP expression from brain slice cells cultured with the 
nanopatterned PDMS pins on either day.  However, it is important to note that cells cultured with 
nanopatterned PDMS pins had a decrease in GFAP gene expression over time and levels were 
below the control on both days.  Meanwhile, cells cultured with the non-patterned pins had an 
increase over time and resulted in GFAP relative gene expression a little higher than the control 
on day seven.   
 
Figure 50. RTPCR GFAP relative gene expression.  The control is represented as the red line.  *p<0.01 
data compared to control on day one. 
There were no significant differences found between patterned and non-patterned 
samples on either day with IL1β relative gene expression (Figure 51).  Nevertheless, it was 
observed that brain slice cells cultured with both patterned and non-patterned PDMS pins had 
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IL1β relative gene expression higher than the control on both days.  Additionally, it is notable 
that cells cultured with patterned PDMS pins showed a slight decrease in IL1β relative gene 
expression over time, while those with non-patterned pins showed a slight increase over time.   
 
Figure 51. RTPCR IL1β relative gene expression.  The control is represented as the red line. 
Brain slice cells cultured with patterned PDMS pins had significantly lower (p<0.01) 
TNFα relative gene expression compared to the control on day one (Figure 52).  Conversely, 
cells cultured with non-patterned PDMS had significantly higher (p<0.01) TNFα relative gene 
expression compared to the control on day one.  Both materials showed a decrease of TNFα 
relative gene expression over time, with patterned having lower TNFα relative gene expression 
compared to non-patterned on both days.     
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Figure 52. RTPCR of TNFα relative gene expression.  The control is represented as the red line.  *p<0.05 
data compared to control at day one. 
There was no significance found between materials and days with the TGFβ1 relative 
gene expression (Figure 53).  However, it is important to note that the cells cultured with the 
non-patterned pins had higher TGFβ1 relative gene expression levels compared to cells cultured 
with the nanopatterned pins on both days.  Moreover, brain slice cells cultured with both 
materials showed an increase of TGFβ1 relative gene expression over time. 
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Figure 53. RTPCR of TGFβ1 relative gene expression.  The control is represented as the red line. 
8.4 Discussion 
Nanofabrication allows for better understanding of cell behavior by mimicking the nano-
world around the cell created by the nanotopographies of the ECM and the nanochemistry that 
composes the cell membrane (Blattler et al., 2006).  It is the ability of a nanomaterial to mimic 
the roughness of natural tissue that is so interesting when designing optimal implants for the 
central nervous tissue.  The mechanism involved with the cellular response to a nanopatterned 
surface is not well understood.  It is thought that the effects of the surface topography either 
directly influence the cell response, or indirectly effect the cell responses through the affects they 
have on the adsorption of proteins (Kriparamanan et al., 2006).  The confocal and SEM results of 
the present study give evidence that nanotopography influences cell response, both 
morphologically and molecularly.  It was shown that topography as small as 120nm wide ridges 
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with a depth of 20nm were sensitive enough to control cell alignment and consequently alter 
gene expression.   
Organotypic tissue slices cultured with nanopatterned PDMS pins demonstrated that the 
cells grew along the nanopattern, while non-patterned PDMS pins had randomly oriented cells 
along the pin.  The aligned morphology of the cells was suspected to cause the differences in the 
gene expression observed between patterned and non-patterned pins.  Topography has been 
shown to influence cell behavior (Bruder et al., 2007; Mieszawska and Kaplan, 2010).  Studies 
done by Shain et al found that astrocytes prefer to grow and adhere onto patterned surfaces of 
varying dimensions over smooth silicon surfaces in vitro (Kriparamanan et al., 2006; Szarowski 
et al., 2003).  Moreover, Yim et al studied effects of human mesenchymal stem cells grown on 
nanopatterned PDMS substrates (Yim et al., 2007).  They found that nanotopography enhanced 
the upregulation of neuronal marker expression, compared to biochemical cues and non-
patterned surfaces (Yim et al., 2007).  The same study demonstrated that nanotopography had a 
significant effect on directing differentiation of adult stem cells (Yim et al., 2007).   Gomez et al 
examined microchannel-patterned PDMS in order to assess the rate of axon initiation and overall 
axon length of embryonic hippocampal neurons (Gomez et al., 2007; Gomez and Schmidt, 
2007).  They found that PDMS microtopography was a crucial factor leading to 68% increase in 
axon initiation (Gomez et al., 2007; Gomez and Schmidt, 2007).   
Typical inflammatory response to brain injury includes activated microglia at the site of 
injury.  Activated microglia rapidly respond to protect neural cells by releasing trophic and anti-
inflammatory factors such as TGFβ1, IL1β and TNFα (Parekkadan et al., 2008).   One of the first 
effectors to be produced is IL-1β.  Herx et al showed activated microglia produce IL-1β within 
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15 minutes following a cortical injury (Herx et al., 2000; Herx and Yong, 2001; Liberto et al., 
2004).  Microglia synthesize and release TGFβ1 following injury, along with proinflammatory 
interleukin-1 and tumor necrosis factor.  TGF-β1 is immediately released after injury, controlling 
the inflammatory and neuronal response (Berdichevsky et al., 2010; Hermanns et al., 2006; 
Klapka and Muller, 2006).  TGFβ1 is an astrocyte derived cytokine that works as a 
neuroprotective in the brain by increasing extracellular matrix protein production, consequently 
resulting in the formation of the glial scar (Farina et al., 2007; Rao et al., 2012).  TNFα is a 
proinflammatory cytokine both astrocytes and microglia produce and act upon in response to 
specific signals (Downen et al., 1999; John et al., 2003; Liberto et al., 2004; Malipiero et al., 
1990).  Studies have shown activated microglia produce 95 times more TNFα than activated 
astrocytes (Liberto et al., 2004; Malipiero et al., 1990).  Like IL-1β, TNFα is released at the 
beginning of reactive astrogliosis and functions to repair damage in the CNS, however it has 
been shown to be directly cytotoxic to neurons (Downen et al., 1999; John et al., 2003).     
Recent work by Herx et al illustrated the importance of IL-1β to the initiation of reactive 
astrogliosis (Herx and Yong, 2001; John et al., 2003). This group demonstrated the presence of 
IL-1β resulted in an up-regulation of GFAP expression in astrocytes (Herx and Yong, 2001; John 
et al., 2003).   Likewise, we found an analogous increase in IL-1β and GFAP with cells on the 
non-patterned PDMS pins, which demonstrates the documents inflammatory response.  To the 
contrary, cells on the nanopatterned surface had a decrease in both IL-1β and GFAP gene 
expression over time.  This evidence suggests a decrease in the inflammatory response, thus 
advocating biocompatibility of the nanopatterned pins.   
Gene expression of GFAP decreased on nanopatterned surfaces over time, while 
increasing on non-patterned surfaces over time.  GFAP relative gene expression remained close 
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to control values on both days and both samples.  These results indicate nanopatterning did 
slightly improve the biocompatibility of the PDMS pins.  Moreover, TGFβ1 gene expression 
increased over time with both patterned and non-patterned samples.  However, TGFβ1 levels 
were lower from brain tissue slices cultured with nanopatterened pins compared to the non-
patterned pins.  In fact, on day one in culture, TGFβ1 gene expression with nanopatterned pins 
was lower than the control.  These results indicate that the nanopatterning inhibits TGFβ1 
expression.  A study done by Logan et al showed inhibition of TGFβ1 prevents reactive 
astrocytes from forming a glial scar around the injury site, and a down-regulation of ECM 
molecules expression, such as laminin and fibronectin (John et al., 2003; Logan et al., 1994).  
Similarly, in vitro studies of TGFβ1 administration to primary astrocyte cultures revealed a 
down-regulation of several proinflammatory gene expression, such as TNFα (Dong and 
Benveniste, 2001; John et al., 2003; Shrikant and Benveniste, 1996; Smith and Hale, 1997).    
These studies also showed TGFβ1 induces the expression of multiple extracellular matrix 
molecules and cytoskeletal components thereby leading to the formation of a glial scar and 
inhibition of neuronal growth (Dong and Benveniste, 2001; Fok-Seang et al., 1998; John et al., 
2003; Shrikant and Benveniste, 1996; Smith and Hale, 1997; Wyss-Coray et al., 2000).   Results 
from this study suggest nanopatterning inhibits TGFβ1 expression, thereby preventing the 
cascade of events leading to glial scar formation.   
Studies have revealed TNFα to be rapidly upregulated in injured or inflamed CNS animal 
models (John et al., 2003; Rostworowski et al., 1997; Taupin et al., 1993).  This upregulation of 
TNFα was exhibited to be concurrent with the increase of GFAP in astrocytes which leads to 
glial scar formation (John et al., 2003; Rostworowski et al., 1997; Taupin et al., 1993).  Results 
of this study are not in accord with previous findings depicting inflammation.  In fact, results 
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from this study showed a decrease in TNFα over time with both nanopatterned and non-patterned 
PDMS pins.  Moreover, it was observed that tissues cultured with the nanopatterned pins had 
lower TNFα levels compared to both the non-patterned and control samples.  These results 
indicate that the nanopattern features inhibit TNFα gene expression which may simultaneously 
lead to the prevention of glial scar tissue formation.   
Tissue cultures with the nanopatterned pins exhibited the typical acute 
neuroinflammatory response, which consists of a reduction of IL1β and TNFα levels over time 
and an increase in TGFβ1 levels over time.  However, there was a decrease in GFAP levels over 
time, indicating the negative feedback mechanism had taken effect, astrocytes did not become 
reactive and the formation of a glial scar was avoided.  On the other hand, tissue cultures with 
non-patterned PDMS pins had an increase of GFAP, IL-1β, and TGFβ1 over time, signifying the 
beginnings of a glial scar.  It was observed that tissue cultures with nanopatterned PDMS pins 
had lower GFAP, IL1β, TNFα, and TGFβ1 relative gene expression compared to non-patterned 
PDMS by day seven.  These results denote nanopatterning of the PDMS pins surface reduces the 
glial cells’ inflammatory response, therefore indicating an improved biocompatibility.    
8.5 Conclusions 
The decreasing trend of GFAP, TNFα, IL-1β gene expression found from cells cultured 
with the nanopatterned PDMS pins indicates a reduction of inflammation.  By day seven, all four 
markers tested were lower with nanopatterned pins compared to non-patterend pins.  Results of 
this study confirm nanopatterning not only influences cell morphology, but molecularly as well.  
These results collectively indicate nanpatterning improves the biocompatibility of PDMS by 
reducing inflammatory markers such as GFAP, IL-1β, TGFβ1 and TNFα compared to the non-
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patterned PDMS pins.  Further investigation including neuron proximity, morphology and 
functionality will enhance our current findings.   
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CHAPTER 9 
9.1 CONCLUSIONS 
These studies have utilized a combination of in vitro techniques in order to assess the 
biocompatibility of biomaterials used for neural electrode fabrication and design.  Initially, the 
astrocyte response was studied to compare the biocompatibility of silicon, platinum, PMMA and 
SU-8.  It is well documented that reactive astrocytes are characterized by hypertrophy, 
hyperplasia, upregulation of GFAP, formation of filaments, enlarged, irregularly shaped nuclei, 
activated cell proliferation site production of a glial scar tissue rich in ECM proteins (Buffo et 
al., 2010; Gervasi et al., 2008; Laird et al., 2008; Polikov et al., 2006; Polikov et al., 2005).  
Therefore, these studies focused on examining these characteristics.  Results indicate little to no 
antimony in the SU-8 formula used in this study, which is evident of the non-cytoxicity of SU-8.  
Moreover, there was at least 93% viability of cells on SU-8 for up to one week in vitro, the initial 
adhesion of cells was strongest on SU-8, the proliferation rates were steady and consistent with 
the control, the morphology of the nucleus was consistent with the control, and GFAP was 
lowest on SU-8 day seven.  Overall, these  observations suggest SU-8 to be biocompatible.   
Results determined the cellular characteristics, reactions and growth rates of astrocytes grown on 
PMMA resembled closely to that of cells grown on the control surface, thus confirming the 
biocompatibility of PMMA.  Additionally, the astrocyte GFAP gene expressions of cells grown 
on PMMA were lower than the control, signifying a lack of astrocyte reactivity.   Furthermore, it 
was shown astrocytes depict reactive characteristics when grown on platinum and silicon 
surfaces, thus rendering the need to find more biocompatible, conducting materials for neural 
electrode fabrication.   
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Based on the findings from the biomaterials study, it was decided to optimize PMMA by 
changing the surface characteristic of the material.  Through the process of hot embossing, 
nanopatterns were placed on the surface in order to test the hypothesis that nanopattterning can 
improve the cellular response to the material.  Results of this study agreed with current literature 
showing that topography effects protein and cell behavior.  Nanopatterning increased the rate of 
protein adsorption, influenced cells to align along the direction of the pattern, inhibited the 
GFAP gene expression, and decreased the amount of cell adhesion compared to the non-
patterned substrate.  Moreover, it was determined that the size of the nanopattern induced 
particular protein and cell responses.  Specifically, it was concluded that for the use in neural 
electrode fabrication and design, the 3600mm/gratings pattern feature sizes were optimal.  The 
3600 mm/gratings pattern depicted cell alignment along the nanopattern, less protein adsorption, 
less cell adhesion, proliferation and viability, inhibition of GFAP and MAP2k1 compared to all 
other substrates tested.   
Results from the initial biomaterials study also indicated platinum was negatively 
affected the cells and may not be a suitable material for neural electrodes.  This lead to pursuing 
studies with iridium oxide and platinum alloy wires for the glial scar assay.  It is known that 
when compared by electrical properties, such as impedance and charge injection capacity, 
iridium oxide has its advantages with lower impedance and a higher charge injection capacity 
compared to platinum.  These advantages would appear to make iridium oxide more favorable 
for neural electrode fabrication. However, results of this study demonstrate that although the 
electrical properties may be better, iridium oxide wires exhibited a more significant reactive 
response as compared to platinum alloy wires.  Astrocytes cultured with platinum alloy wires 
had less GFAP gene expression, lower average GFAP intensity, and smaller glial scar thickness.  
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Collectively, these results indicated that platinum alloy wires were more biocompatible than the 
iridium oxide wires.   
Results from the nanopatterning PMMA study prompted a more thorough investigation 
of the nanopatterning effects using an organotypic brain slice model.  PDMS was utilized as the 
substrate due to its optimal physical properties.  PDMS is highly viscoelastic, which made it 
possible to roll after it was nanopatterned.  Confocal and SEM imaging illustrated cells from the 
brain tissue slices were aligned along the nanopattern on the PDMS pins.  Decreases in several 
inflammatory markers (GFAP, TNFα, IL-1β) determined from gene expression analysis, was 
shown with the nanopatterned PDMS pins.  By day seven, all four markers tested were lower 
with nanopatterned pins compared to non-patterend pins.  Results of this study confirm 
nanopatterning not only influences cell morphology, but alters molecular cascades within the 
cells as well.  These results collectively indicate nanpatterning improves the biocompatibility of 
PDMS by reducing inflammatory markers such as GFAP, IL-1β, TGFβ1 and TNFα compared to 
the non-patterned PDMS pins.   
The results of these studies provide essential information for the neural electrode research 
community.  There is a lack of information available in the scientific community on acceptable 
and effective materials for neural electrode fabrication.  The results of the presented studies 
provide more information which could lead to classifying guidelines to create biocompatible 
neural electrode materials.   
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CHAPTER 10 
10.1 FUTURE WORK 
Based on the results of these studies, there are several possible directions for future 
investigations. 
1.  The present study demonstrated the importance of biocompatibility testing of 
materials used in neural electrode fabrication.  These studies mainly focused on the 
astrocyte response to the materials.  Future studies focusing on the microglia, 
oligodendrocyte and neuron response to materials is imperative to fully grasp the 
biocompatibility of the materials used in neural electrodes.  Research has shown different 
cells have various responses to materials and topographies, therefore it is imperative to 
assure all brain cells are biocompatible with materials used in neural electrode 
fabrication.   
• Microglia reactivity assessment based on cell morphology, proliferation, viability, 
adhesion, and gene expression of inflammatory cytokines should be studied.  In 
vitro investigation of a microglia cell line grown on non-patterned biomaterials 
and nanopatterned biomaterials is required to fully understand the inflammatory 
response to these materials.   
• Neuron proximity, morphology and functionality should be conducted to 
determine if the neural electrode materials attract and excite neurons.  Preliminary 
in vitro studies utilizing a neuronal cell line in order to examine the neuron 
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morphology, adhesion, viability, and proximity to recording sites on the material 
are necessary.   
• Mixed cell cultures consisting of neurons and oligodendrocytes should be grown 
on the biomaterials.  In which case, oligodendrocyte proximity to neurons and 
functionality to provide ample myelin sheath around axons will be examined. 
2.  Future studies employing either the glial assay or the organotypic brain slice model 
from the current studies will enhance the understanding of the physiological and 
functional neuronal response to the material in an in vitro setting.  Neuron 
electrophysiology is a vital need for final assessment of the biomaterials.  Therefore, 
these studies should incorporate techniques such as the patch clamp in order to assess the 
performance of the neurons with the electrode materials under investigation.   
3.  The nanopatterning used in these studies proved to encourage cell alignment and 
decrease glial cell reactivity.  Additional exploration of surface modifications based on 
the findings from these studies may continue to improve glial cells biocompatibility and 
enhance neuron functionality.  Further investigation on various nanopattern geometries 
based on the feature sizes presented in these studies may demonstrate further increases in 
biocompatibility of biomaterials.   
4.  Chronic studies evaluating glial scarring in an in vivo setting will add to the results of 
these studies.  In vitro studies have time limitations due to cellular confluence and the 
natural process of apoptosis that occurs once confluence is surpassed.  Therefore, in order 
to assess the glial scarring occurring in chronically implanted neural electrodes, an in vivo 
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model should be utilized to test novel and optimized biomaterials which have passed in 
vitro biocompatibility testing.   
5.  These studies evaluated numerous materials used in all aspects of neural electrode 
fabrication; materials employed for the conducting surface, as well as material used as 
backbone support and insulation.  Based on these findings, a neural electrode prototype 
design utilizing these materials and topographies may proceed.   
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ABSTRACT 
STUDYING THE GLIAL CELL RESPONSE TO BIOMATERIALS AND SURFACE 
TOPOGRAPHY FOR IMPROVING THE NEURAL ELECTRODE INTERFACE 
 
by 
EVON EREIFEJ 
MAY 2012 
Advisor: Pamela J. VandeVord 
Major: Biomedical Engineering 
Degree: Doctor of Philosophy 
Neural electrode devices hold great promise to help people with the restoration of lost 
functions, however, research is lacking in the biomaterial design of a stable, long-term device.  
Current devices lack long term functionality, most have been found unable to record neural 
activity within weeks after implantation due to the development of glial scar tissue (Polikov et 
al., 2006; Zhong and Bellamkonda, 2008).  The long-term effect of chronically implanted 
electrodes is the formation of a glial scar made up of reactive astrocytes and the matrix proteins 
they generate (Polikov et al., 2005; Seil and Webster, 2008).  Scarring is initiated when a device 
is inserted into brain tissue and is associated with an inflammatory response.  Activated 
astrocytes are hypertrophic, hyperplastic, have an upregulation of intermediate filaments GFAP 
and vimentin expression, and filament formation (Buffo et al., 2010; Gervasi et al., 2008).   
Current approaches towards inhibiting the initiation of glial scarring range from altering 
the geometry, roughness, size, shape and materials of the device (Grill et al., 2009; Kotov et al., 
2009; Kotzar et al., 2002; Szarowski et al., 2003).    Literature has shown that surface topography 
modifications can alter cell alignment, adhesion, proliferation, migration, and gene expression 
(Agnew et al., 1983; Cogan et al., 2005; Cogan et al., 2006; Merrill et al., 2005).  Thus, the goals 
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of the presented work are to study the cellular response to biomaterials used in neural electrode 
fabrication and assess surface topography effects on minimizing astrogliosis.   
Initially, to examine astrocyte response to various materials used in neural electrode 
fabrication, astrocytes were cultured on platinum, silicon, PMMA, and SU-8 surfaces, with 
polystyrene as the control surface.  Cell proliferation, viability, morphology and gene expression 
was measured for seven days in vitro.  Results determined the cellular characteristics, reactions 
and growth rates of astrocytes grown on PMMA resembled closely to that of cells grown on the 
control surface, thus confirming the biocompatibility of PMMA.  Additionally, the astrocyte 
GFAP gene expressions of cells grown on PMMA were lower than the control, signifying a lack 
of astrocyte reactivity.    
Based on the findings from the biomaterials study, it was decided to optimize PMMA by 
changing the surface characteristic of the material.  Through the process of hot embossing, 
nanopatterns were placed on the surface in order to test the hypothesis that nanopattterning can 
improve the cellular response to the material.  Results of this study agreed with current literature 
showing that topography effects protein and cell behavior.  It was concluded that for the use in 
neural electrode fabrication and design, the 3600mm/gratings pattern feature sizes were optimal.  
The 3600 mm/gratings pattern depicted cell alignment along the nanopattern, less protein 
adsorption, less cell adhesion, proliferation and viability, inhibition of GFAP and MAP2k1 
compared to all other substrates tested.   
Results from the initial biomaterials study also indicated platinum was negatively 
affected the cells and may not be a suitable material for neural electrodes.  This lead to pursuing 
studies with iridium oxide and platinum alloy wires for the glial scar assay.  Iridium oxide 
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advantages of lower impedance and higher charge injection capacity would appear to make 
iridium oxide more favorable for neural electrode fabrication. However, results of this study 
demonstrate iridium oxide wires exhibited a more significant reactive response as compared to 
platinum alloy wires.  Astrocytes cultured with platinum alloy wires had less GFAP gene 
expression, lower average GFAP intensity, and smaller glial scar thickness.   
Results from the nanopatterning PMMA study prompted a more thorough investigation 
of the nanopatterning effects using an organotypic brain slice model.  PDMS was utilized as the 
substrate due to its optimal physical properties.  Confocal and SEM imaging illustrated cells 
from the brain tissue slices were aligned along the nanopattern on the PDMS pins.  Decreases in 
several inflammatory markers (GFAP, TNFα, IL-1β) determined from gene expression analysis, 
was shown with the nanopatterned PDMS pins.  Results of this study confirm nanopatterning not 
only influences cell morphology, but alters molecular cascades within the cells as well.   
The results of these studies provide essential information for the neural electrode research 
community.  There is a lack of information available in the scientific community on acceptable 
and effective materials for neural electrode fabrication.  The results of the presented studies 
provide more information which could lead to classifying guidelines to create biocompatible 
neural electrode materials.   
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